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SUMMARY 
 
A large numbers of people in rural areas consume raw milk and its products. People believe 
that raw milk and its products have advantages or value over the pasteurized one. The 
presence of foodborne pathogens in unpasteurized raw milk either directly or indirectly 
increases the risk of ingestion and transmission of food-borne pathogens and potentially 
harmful toxins. Microbes may gain entry into raw milk directly from dairy cows experiencing 
sub-clinical or clinical mastitis. Mastitis in cattle is induced when pathogenic microorganisms 
enter the udder through the teat canal, overcome the cow’s defense mechanisms, begin to 
multiply in the udder, and produce toxins that are harmful to the mammary gland. The 
objectives of this study were to determine the prevalence of E. coli in unpasteurized milk 
recovered from Middledrift and Fort Hare dairy farms, to characterize the identified isolates 
into different pathotypes, to determine the antibiogram of the isolates and to characterize the 
genes responsible for antibiotic resistance. In this study identification of these mastitic 
pathogens was done by molecular based methods (polymerase chain reaction) and antibiotic 
susceptibility testing was done using the disk diffusion method and the genes responsible for 
antibiotic resistance were detected by PCR. Target genes (fliCH754 (63%), eae 28 (32%), lt 
27 (31%), eagg 12 (14%), ial 6 (7%), papC 4 (5%) and daaE 2 (2%)) that encode 
pathogenicity for E. coli were successfully amplified by PCR confirming that the isolates 
were pathogenic strains. In this study multiple resistances of the pathogenic E.coli isolates 
were found in the tested antimicrobial agents. Penicillin G and erythromycin showed 100% 
resistance. The strA gene which encodes for streptomycin and the tetA gene which encodes 
for tetracycline were not present in the isolates using conventional PCR. The results in this 
study demonstrates that there is a widespread distribution of potentially virulent E. coli 
strains in the environment and in food that may be a cause of concern for human health and 
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the phenotypic showed total resistance to erythromycin and penicillin G. Monitoring of 
mastitis and antimicrobial resistance (AMR) in bacteria is of great importance and has 
clinical and public health significance. 
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CHAPTER ONE  
 
1.1 GENERAL INTRODUCTION 
 
Raw unpasteurized milk is a white liquid produced by the mammary glands of cows and it is 
the primary source of nutrition to calves and some humans. Raw milk is a well-known good 
medium that supports the growth and multiplication of many kinds of microorganisms due to 
its complex biochemical composition and high water activity (Murinda et al., 2004; Oliver et 
al., 2005). It is well known that freshly obtained milk contain some bacteria and somatic 
cells, which constitute the biological constituents of the milk, which easily change depending 
on production conditions, such as the health status of the cattle and hygiene practices during 
milking as well as keeping and transportation of milk and milk products (Turner and Veary, 
1990, Lues et al., 2010). Pasteurization of milk is a key component in control of milk-borne 
pathogens that threaten public health (Holsinger et al., 1997). It was originally developed for 
the control of infection due to brucellosis and tuberculosis from infected cattle, but also 
controls a wide range of other human pathogens (Tetra Pak Processing System AB, 1995). A 
large number of people in rural areas consume raw milk and raw milk products via 
consumption of several types of cheeses. People believe that raw milk and their products 
have advantages or value over the pasteurized one (Oliver et al., 2009; Guh et al., 2010). The 
presence of food-borne pathogens in unpasteurized raw milk either directly or indirectly 
increases the risk of ingestion and transmission of food-borne pathogens and ingestion of 
potentially harmful toxins. Microbes may gain entry into raw milk directly from dairy cows 
experiencing sub clinical or clinical mastitis (Rodojcic-Prodaova and Necev, 1991).  
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Mastitis is defined as an inflammation of the mammary gland (International Dairy 
Federation, 1987). It is induced when pathogenic microorganisms enter the udder through the 
teat canal, overcome the cow’s defense mechanisms, begin to multiply in the udder, and 
produce toxins that are harmful to the mammary gland. Mammary tissue is then damaged, 
which causes increased vascular permeability.  Mastitis can occur in all mammals, including 
humans (Hurley and Morrin, 1997, Oliveirra et al., 2000).  
 
Mastitis can either be clinical or subclinical. Clinical mastitis occurs when visible sign of 
inflammation is observed in the udder of the cow or the teats. The clinical case could be 
subacute, where the symptoms are very mild and may only be accompanied by slight 
swelling of the udder and the presence of the flakes in the milk. An acute or peracute case of 
clinical mastitis may occur where a sudden onset of symptoms such as severe inflammation 
of the teats, fever, loss of appetite, dehydration and even death occurs. Clinical mastitis will    
eventually lead to chronic mastitis if not treated. In cases of chronic mastitis, the cow will 
suffer from a constant infection oscillating between sub-acute and acute clinical mastitis. A 
permanent change in the udder may occur with the presence of scar tissue and a change in the 
shape and size of the glandular tissue (Giesecke et al., 1994; Philpot and Nickerson, 1999; 
Akers, 2002). Subclinical mastitis proceeds clinical mastitis and is more subtle in that no 
signs of infection are visible. However, special screening tests, such as California Mastitis 
Test (CMT), Wisconsin Mastitis Test (WMT) and the catalase test are utilized to show 
changes in the milk. This type of mastitis is referred to as ―hidden‖. Most dairy herds will 
have cows with subclinical mastitis. The only way to detect the presence of infecting 
microorganisms invading the teat canal and udder tissue is to monitor the inflammatory 
response of the cows, i.e. quantification of the somatic cells in the milk (Giesecke et al., 
1994; Philpot and Nickerson, 1999). Subclinical mastitis is considered more severe than  
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clinical mastitis, as early detection is impossible without regular monitoring. Cows with 
subclinical mastitis harbor a constant reservoir of pathogens that could lead to severe udder 
infection and spreading to other cows (Philpot and Nickerson, 1999). Many types of microbes 
can cause the infection and can be transmitted through both environmental sources (for 
example, contaminated water, soil, bedding) and from contagious sources (from other 
infected cows). Bacteria (pathogens) (or other dairy animals) can be a source of disease 
causing mastitis in cows and spoilage organisms in milk. 
 
Microorganisms that are responsible for mastitis and spoilage of milk are among others 
Staphylococcus aureus, Streptococcus agalactiae, Corynebacterium bovis, Mycoplasma 
species, Streptococcus uberis (Erskine, 2002), coliforms (Escherichia coli, (E. coli) 
Klebsiella species and Enterobacter aerogenes), Serratia, Pseudomonas, Proteus species, 
environmental Streptococci, Enterobacter species (Smith and Hogen, 1993; Quinn et al., 
2002). Identification of theses pathogens could be done by phenotypic, genotypic or serotype 
based methods (Christen et al., 1993; Paton and Paton, 1998; Vidal et al., 2004; Todar, 
2008). The consequences of a milk-borne infection may be limited to the common symptoms 
of diarrhoea, vomiting, nausea, fever, abdominal cramps etc., but a certain percentage of 
persons can develop more severe clinical symptoms such as Guillian-Barre’ syndrome 
(Camylobacter spp.) and haemolytic uremic syndrome (HUS) (E. coli 0157:H7) or long term 
and sometimes chronic complications e.g. reactive arthritis or even death (Griffiths, 2010).  
 
1.2 Statement of the problem 
 
E. coli is an environmental pathogen found in the immediate surroundings of the cow such as 
the soil, grass, manure and the bedding of housed cows. It is therefore easy for the organism 
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to be found in the udder of cow thereby gaining entrance to the milk (Hogan and Smith, 
2003). Its status as a true pathogen is of public health significance. It produces toxins that 
destroy cell membrane and can directly damage milk-producing tissues which can lead to 
bovine mastitis (Jones et al., 1998). The high prevalence of intramammary E. coli infection 
indicates the potential of a food hazard, which could have grave consequence to those who 
consume raw milk. Antimicrobials are used frequently for treatment and prevention of bovine 
mastitis. Therefore to successfully control mastitis and to circumvent potential problems 
associated with bacterial resistance and treatment failure, it is important to study 
antimicrobial resistance profiles of mastitis pathogens, especially so as there are seemingly 
no such studies reported in the environment of the Eastern Cape Province. 
 
1.3 Hypothesis- 
Dairy milk is a point source of pathogenic E. coli strains.  
 
1.4 Aim-  
The study aims at assessing the microbiological quality of Escherichia coli in raw 
unpasteurized milk and to detect the genes that mediate resistance. 
 
1.5 Objectives: 
 
 To determine the prevalence of E. coli in unpasteurized milk recovered from 
Middledrift and Fort Hare dairy. 
 To characterize the identified isolates into different pathotypes. 
 To determine the antibiogram of the pathotypes and to characterize the genes 
responsible for antibiotic resistance. 
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CHAPTER TWO  
 
 
LITERATURE REVIEW 
  
2.1 Escherichia coli (E. coli) 
 
The genus Escherichia derives its name from Theodor Escherich, who first isolated this 
organism from feces in 1885. E. coli is a member of the Enterobacteriaceae (the intestinal 
bacteria) and belongs to the order Enterobacteriales and Kingdom Eubacteria (Berg, 1978). 
These bacteria are facultative anaerobes, Gram negative short rods that can grow under both 
aerobic and anaerobic conditions (Chapelle, 2001). If molecular oxygen is available, the 
bacteria rely on respiratory metabolism to survive, while the absence of molecular oxygen; 
the organisms use fermentation as an alternate means of survival (Berg, 2000; Chapelle, 
2001). Bacteria belonging to the genus Escherichia are motile by means of 
peritrichous/multiple flagellum and are unable to form spores to survive unfavorable 
environmental conditions (Todar, 2008). E. coli typically colonizes gastrointestinal tract of 
humans and animals within a few hours after birth. Usually E. coli and its human host coexist 
in good health and with mutual benefit for decades. These commensal E. coli strains rarely 
cause disease except in immunocompromised hosts or where the normal gastrointestinal 
barriers are breached (Kaper et al., 2004) E. coli is recognized as an important zoonotic 
pathogen, not because of the number of cases of human illness it causes, but by the serious 
and life threatening disease that a small number of E. coli strains may cause. Outbreaks of 
pathogenic E. coli like the German outbreak in 2011 and the outbreak related to Godstone 
Farm in Surrey in 2009 have a high profile in the media as a result of the serious illness 
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caused. The number of cases of foodborne disease associated with E. coli in the UK is around 
a thousand, dwarfed by an estimated 700,000 cases of Campylobacter infection. Although 
infection with pathogenic E. coli is rare in the UK, it is the serious and sometimes fatal 
diseases it may cause that give it a high importance (Pennington, 2010). 
 
2.2 E. coli virulence factors 
  
Pathogenic E. coli bacteria are typically specific to the type of disease they cause and to the 
animal species infected. They produce virulence factors involved in pathogenesis of specific 
diseases (Kaper et al., 2004). Bacterial virulence factors are required to colonize and infect 
the host and to fight host defense mechanisms. Major groups of E. coli virulence factors 
include toxins, adhesins, proteins secreted into host cells, polysaccharide capsules and O-
antigens, and other mechanisms to resist killing by complement or to scavenge iron (Keller et 
al., 2002). Bacteria do not produce virulence factors constantly but only upon receiving 
certain signals from the host or environment (Keller et al., 2002). The genes for virulence 
factors may be present in the bacterial genome or may reside extrachromosomally on 
plasmids, even though the virulence factor is not produced (Harel and Martin, 1999; Kaper et 
al., 2004, Smith et al., 2007). 
 
2.2.1 Adhesins 
 
Adhesins are either hair-like appendages known as fimbriae or pili, or afimbrial adhesins 
associated with the cell surface (Soto and Hultgren, 1999; Kaper et al., 2004). Bacteria need 
adhesins to adhere to and colonize the host cell surface. Different adhesins have been 
detected in E. coli isolates associated with bovine diseases. The family of F17 fimbriae 
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includes F17a expressed by bovine enterotoxigenic E.coli, F17b expressed by E. coli isolated 
from septicaemic and diarrhoeic calves and lambs, F17c isolated from septicaemic E. coli 
strains and F17d described in bovine enterotoxigenic E. coli and E. coli isolated from 
diarrhoeic calves (Le Bouguenec and Bertin, 1999). The F17 fimbriae are often associated 
with other virulence factors in pathogenic E. coli. Genes encoding F17 fimbriae are located 
on the chromosome (Bertin et al., 1996; Treng et al., 2002). In the study of Pohl and Mainil 
(1995), almost half of the F17-positive E. coli strains were resistant to complement and 
produced aerobactin. S and P fimbriae are usually found in E. coli strains causing urinary 
tract infection (Soto and Hultgren, 1999). They are probably needed for adherence of bacteria 
to urinary tract epithelia and are suggested to be involved in recurrent urinary tract infections 
(Schilling et al., 2001). Genes encoding S and P fimbriae are located on the chromosome 
(Mainil et al., 1997). Afimbrial adhesins are encoded by different afa genes; afa-7 and afa-8 
have been found in bovine isolates, afa-8 being more common than afa-7 (Lalioui et al., 
1999). Afa-8 genes have been detected on plasmids, which also carried genes for F17c and 
cytotoxic necrotizing factor 2 (CNF2) (Le Bouguenec and Bertin, 1999). Another afimbrial 
adhesin found in bovine pathogenic E. coli strains is the capsule-like structure called CS31A 
adhesin (Le Bouguenec and Bertin, 1999). It has been described in E. coli strains from calves 
with septicaemia or diarrhoea (Contrepois et al., 1986; Mercado et al., 2003). The genes 
encoding CS31A have been detected on large plasmids carrying genes for other virulence 
factors, such as aerobactin and F17c fimbriae, as well as for antimicrobial resistance 
(Contrepois et al., 1986). 
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2.2.2 Toxins 
 
Pathogenic E. coli strains may produce a variety of toxins with different activities: heat-labile 
(LT) and heat-stable (ST) enterotoxins, shiga toxins and cytotoxic necrotizing factors 1 and 2 
(CNF1 and CNF2). Shiga toxins are produced by enterohaemorrhagic E. coli strains (Riley et 
al., 1983; De Rycke and Oswald, 2001). Enterotoxigenic strains usually produce two 
enterotoxins, LT and ST, which have distinct roles in the pathogenesis. E. coli isolates 
producing CNF2 are common in cattle (Pohl et al., 1993). Many of these strains also produce 
F17b fimbriae and aerobactin and are resistant to the killing action of serum. The CNF1-
positive strains are typically isolated from extraintestinal infections and are mainly positive 
for adhesins of the P and S fimbrial families or the Afa family (Mainil et al., 1999; Bertin et 
al., 1998). The production of CNF1 is chromosomally encoded, whereas CNF2 is encoded by 
genes located on a plasmid (Falbo et al., 1992; Mainil et al., 1999). 
 
2.2.3 Aerobactin 
 
Iron is an essential element for the survival and multiplication of E. coli. Aerobactin is one of 
the siderophores present in Gram-negative bacteria. It chelates iron, making it available for 
bacterial use. The gene for aerobactin is located either on a chromosome or on a plasmid, 
where many of the antimicrobial resistance genes are also located (Vidotto et al., 1991; 
Johnson et al., 2002). 
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2.2.4 Factors conferring serum resistance 
 
Serum resistance is one of the most studied virulence properties of Gram-negative bacteria. 
Resistance to the killing action of serum is linked to structures at or near the bacterial surface. 
Capsule or outer membrane proteins, like OmpA and TraT, have been suggested to interfere 
with complement components and the membrane attack complex, preventing the killing 
action (Ward and Sebunya, 1981; Taylor, 1983; Weiser and Gotschich, 1991; Pramoonjago et 
al., 1992). TraT is a cell surface-exposed lipoprotein, which is assumed to inhibit the correct 
assembly or membrane insertion of the membrane attack complex of complement (Sukupolvi 
and O’Connors, 1990). TraT is encoded by the traT gene carried on large conjugative 
plasmids. The K1 capsular antigen protects E. coli from the killing effect of serum and has 
been thought to co-operate with TraT (Montenegro et al., 1985) However, in clinical studies 
(Nemeth et al., 1991; Wooley et al., 1993; Pfaff McDonough et al., 2000; Todar, 2008), no 
relation of K1 to serum resistance or the traT gene could be detected. 
 
2.3 PATHOGENIC TYPES OF E.  coli 
 
Certain isolates of E. coli have been implicated in a wide range of diseases that affect either 
animals or humans worldwide. Pathogenic E. coli are responsible for three types of infections 
in humans: urinary tract infections (UTI), neonatal meningitis, and intestinal diseases 
(gastroenteritis) (Todar, 2008). The diseases caused by a particular strain of E. coli depend on 
distribution and expression of an array of virulence determinants, including adhesins, 
invasins, toxins, and abilities to withstand host defences. All diarrheagenic strains of E. coli 
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were initially termed enteropathogenic E. coli, but when more was learnt about their 
pathogenic mechanisms, they were grouped into eight pathotypes (Kaper et al., 2004).To 
date, eight pathovars and their mechanisms of disease have been extensively studied (Kaper 
et al., 2004). These pathovars can be broadly classified as either diarrheagenic E. coli or 
extraintestinal E. coli (ExPEC). Six pathovars - enteropathogenic E. coli (EPEC), 
enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), Enteroinvasive E. coli 
(EIEC; including Shigella), Enteroaggregative E. coli (EAEC) and diffusely adherent E. coli 
(DAEC) - are diarrhoeagenic, and two pathovars – Uropathogenic E. coli (UPEC) and 
neonatal meningitis E. coli (NMEC) - are the most common ExPEC isolates. Other pathovars 
(necrotoxigenic E. coli, cell detaching E. coli and adherent invasive E. coli) have been 
identified, but their mechanisms of pathogenesis are not as well defined (Croxen and Finlay, 
2010). 
 
2.3.1 ENTEROTOXIGENIC E. coli 
 
Enterotoxigenic E. coli (ETEC) produce the E. coli heat-labile (LT) and/or heat-stable (ST) 
toxins. The ST are of low molecular size and resistant to boiling for 30 minutes (Todar, 2008; 
Croxen and Finaly, 2010). There are several variants of ST, of which ST1a or STp is found in 
E. coli isolated from both humans and animals, while ST1b or STh is predominant in human 
isolates only. The ST enterotoxins are peptides of molecular weight about 4,000 daltons. 
Their small size explains why they are not inactivated by heat. The LTs are high-molecular-
weight proteins similar to cholera toxin and consist of five enterocyte-binding B subunits and 
a biologically active A subunit. The internalized A subunit causes electrolyte imbalance and a 
net fluid loss to the gut lumen by activation of adenylatecyclase and accumulation of cyclic 
adenosine monophosphate. ETEC are important causes of diarrhoea among children in 
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developing countries and of traveler’s diarrhoea (Kaper et al., 2004). Symptoms include 
acute watery diarrhoea that may be mild and of short duration and which in some cases is 
similar to cholera. ETEC strains are host specific, that is, some strains can cause diarrhoea in 
young animals (e.g., calves, lambs, and piglets), while other strains will specifically infect 
only piglets, and others only humans. The prevention of the spread of this strain of 
diarrheagenic E. coli depends on ensuring appropriate sanitary measures; hand-washing and 
proper preparation of food; chlorination of water supplies; and appropriate sewage treatment 
and disposal. Parenteral or oral fluid and electrolyte replacement is used to prevent 
dehydration, and broad-spectrum antibiotics are used in chronic or life-threatening cases, but 
in most cases, should be avoided because of severe side effects. The major virulence factors 
of ETEC are intestinal colonization factors, for example, fimbriae, and the enterotoxins 
(Todar, 2008).The host specificity of individual strains is determined by the type of 
colonization factors and fimbriae produced (Kaper and Nataro, 1998). 
 
2.3.2 ENTEROPATHOGENIC E. coli 
 
Enteropathogenic E. coli (EPEC) is a major cause of potentially fatal diarrhoea in infants in 
developing countries (Kaper et al., 2004). This pathovar belongs to a family of pathogens that 
form attaching and effacing (A/E) lesions on intestinal epithelial cells; other members of the 
family include EHEC, rabbit diarrhoeagenic E. coli (RDEC), the murine pathogen 
Citrobacter rodentium and the recently identified Escherichia albertii (formerly known as 
Hafnia alvei), a pathogen that is associated with diarrhoea in humans. EPEC induce a profuse 
watery, sometimes bloody, diarrhoea. Outbreaks have been linked to the consumption of 
contaminated drinking water as well as some meat products. Pathogenesis of EPEC involves 
a plasmid-encoded protein referred to as EPEC adherence factor (EAF) that enables localized 
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adherence of bacteria to intestinal cells and a non fimbrial adhesin designated intimin, which 
is an outer membrane protein that mediates the final stages of adherence. They do not 
produce ST or LT toxins (Todar, 2008). EPEC strains are said to be "moderately-invasive", 
meaning they are not as invasive as Shigella, and unlike ETEC or EAEC, they cause an 
inflammatory response. The diarrhoea and other symptoms of EPEC infections probably are 
caused by bacterial invasion of host cells and interference with normal cellular signal 
transduction, rather than by production of toxins (Todar, 2008). 
 
2.3.3 ENTEROINVASIVE E. coli 
 
It is generally accepted that EIEC and Shigella should form a single pathovar, because they 
have the same mechanisms of pathogenicity. However, the genus name Shigella is still used 
owing to its association with the disease shigellosis and is retained in this section. Shigella 
are highly infectious bacteria that cause bacillary dysentery and bloody diarrhoea (Kaper et 
al., 2004). This pathovar differs from the other E. coli pathovars, because it includes obligate 
intracellular bacteria that have neither flagella nor adherence factors. Virulence is largely due 
to a 220 kb plasmid that encodes a T3SS on the Mxi–Spa locus that is required for invasion, 
cell survival and apoptosis of macrophages (Vieira et al., 2007). Patients may first develop 
watery diarrhoea prior to onset of dysentery with a low volume of stools containing blood 
and mucus. Other symptoms are headache, fever, and cramping. Humans appear to be the 
main reservoir of EIEC, with little evidence to support EIEC carriage in animals or foods of 
animal origin. EIEC outbreaks are usually associated with water or food contaminated with 
human faeces or person-to-person transmission (Maurelli et al., 1998).  
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The incidence of the disease caused by EIEC is generally low in developed countries 
(Maurelli et al., 1998). Unlike typical E. coli, EIEC are non-motile, do not decarboxylate 
lysine and do not ferment lactose. Pathogenicity of EIEC is primarily due to its ability to 
invade and destroy colonic tissue. The invasion phenotype, encoded by a high molecular 
weight plasmid, can be detected by PCR and probes for specific for invasion genes (Todar, 
2008). 
 
2.3.4 ENTEROAGGREGATIVE E. coli  
 
Enteroaggregative Escherichia coli (EAEC) was originally identified as the etiologic agent of 
persistent diarrhea in developing countries but is gaining increasing prominence for its role in 
a wider spectrum of diarrheal syndromes. EAEC strains have been implicated in acute as well 
as persistent diarrhoea among adults and children (Okeke and Nataro, 2001; Huang et al., 
2004).A recent meta-analysis found that EAEC is significantly associated with disease in 
every group at high risk for diarrhea, including young children, human immunodeficiency 
virus-positive individuals, and visitors to developing countries (Haung et al., 2006). In 
addition to its association with disease in epidemiological studies in developing countries, 
EAEC has also been identified as a principal cause of diarrheal disease in Germany, the 
United Kingdom, and the United States (Huppertz et al., 1997; Tompkins et al., 1999; Cohen 
et al., 2005;   Bhargava et al., 2009). Aggregative adherence is the defining characteristic of 
EAEC (Nataro et al., 1987). EAEC strains adhere to the intestinal epithelium, and to 
epithelial cells in culture, in a characteristic two-dimensional―stacked brick‖ fashion. The 
pattern features bacteria adhering to the eukaryotic surface, other bacteria, and the solid 
substratum. Four types of fimbriae have so far been documented as conferring aggregative 
adherence (Nataro et al., 1992; Czeczulin et al., 1997; Berneir et al., 2002; Dudley et al., 
18 
 
2006). Two noncontiguous plasmid loci containing the complete complement of genes 
encoding aggregative adherence fimbriae I (AAF/I) or AAF/II are sufficient to confer 
aggregative adherence on non-adherent E. coli (Steiner et al., 2000). The plasmid bearing 
type IV pili found in Serbian EAEC outbreak strain C1096 are also sufficient to confer a 
weak aggregative adherence phenotype on E. coli K-12.Enteroaggregative E. coli (EAEC) is 
found mostly in humans. Although it is considered to be an emerging pathogen, EAEC is the 
second most common cause of travellers’ diarrhoea after ETEC in both developed and 
developing countries. EAEC is also becoming commonly recognized as a cause of endemic 
and epidemic diarrhoea worldwide. Diarrhoea caused by EAEC is often watery, but it can be 
accompanied by mucus or blood. EAEC colonization can occur in the mucosa of both the 
small and large bowels, which can lead to mild inflammation in the colon. Much like the 
details of its transmission and epidemiology, the understanding of EAEC and its pathogenesis 
is limited, in part owing to the paucity of suitable animal models and the heterogeneity of 
virulence factors (Kaper et al., 2004). These strains are associated with persistent diarrhoea in 
young children. They resemble ETEC strains in that the bacteria adhere to the intestinal 
mucosa and cause non-bloody diarrhoea without invading or causing inflammation (Todar, 
2008). 
  
2.3.5 ENTEROHEMORRHAGIC E. coli 
 
The enterohaemorrhagic E. coli (EHEC) group has a common ability to produce cytotoxins 
that are active on monkey kidney (Vero) tissue culture cells. These cytotoxins are mediated 
by genes carried by lysogenic bacteriophages and act in a similar manner by interfering with 
protein synthesis in eukaryotic cells (Todar, 2008). The toxins belong to two major 
antigenically distinct groups, stx1 and stx2, with various subgroups. Stx1 is similar to the 
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Shiga toxin produced by Shigella dysenteriae; consequently, Shiga toxin-producing E. coli 
are referred to as both STEC (Shiga toxin-producing E. coli) and VTEC (verotoxigenic E. 
coli) (Kaper and Nataro, 1998). EHEC is a term commonly used to refer to those STEC that 
cause enterohaemorrhagic disease. Since their recognition in the 1980s, EHEC have become 
the most notable of the enteropathogenic E. coli (EPEC) that are transmitted by food, 
including dairy products. They can cause illness in humans and diarrheal illness in young 
animals. Human EHEC infection can be asymptomatic or result in symptoms ranging from 
mild diarrhea to hemorrhagic colitis and life-threatening hemolytic–uremic syndrome (HUS) 
(Croxen and Finlay, 2010). Strains causing hemorrhagic syndromes frequently, but not 
exclusively, carry accessory virulence factors to the Shiga toxins located on a chromosomal 
pathogenicity island, the locus for enterocyte effacement (LEE). The LEE encodes genes that 
lead to the formation of attaching and effacing lesions typically seen in the intestinal 
epithelium in both EHEC and EPEC infections (Kaper et al., 2004). There are many 
serotypes of STEC, although a limited number are commonly associated with HUS. The most 
common is the O157:H7 serotype and others include O26, O111, O45, and O103. Clinical 
isolates of these types often carry the same virulence determinants, for example, Stx1 and/or 
Stx2, the LEE, and pEHEC. Transmission to humans usually occurs through contaminated 
food and water. In North America, Japan and parts of Europe, most outbreaks are due to 
EHEC serotype O157:H7, whereas other serotypes are important health concerns in other 
developed countries (Kaper et al., 2004). Almost all EHEC O157:H7 isolates harbour a 92 kb 
virulence plasmid called pO157, which has approximately 100 ORFs and encodes several 
virulence factors.  
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2.3.6 DIFFUSELY ADHERENT E .coli 
 
Diffusely adherent E. coli (DAEC) are those that produce a more diffuse adherence on the 
Hep-2 cell surface (Scaletsky et al., 2002), and have been recognized as the sixth class of 
diarrheagenic E. coli (Lopes et al., 2005). DAEC is most commonly associated with age-
dependent diarrhoea and in children less than 12 months of age (Scaletsky et al., 2002), 
however most case-control studies have demonstrated that the association of DAEC as a 
diarrhoea causing agent remains controversial. There are a limited number of studies 
regarding the virulence and pathogenic mechanisms of DAEC. It is presumed that the 
virulence factor of the organism is diffuse attachments to the intestinal lining of the infected 
host (Sarkar, 2008). In a study carried out by Meraz et al., 2008, the major clinical symptoms 
of the patients carrying DAEC strains were found to include watery diarrhoea in some 
instances with mucus and blood, vomiting, with vomiting being more prominent as compared 
to diarrhoea among children (Meraz et al., 2008). 
 
2.3.7 UROPATHOGENIC E. coli 
 
Uropathogenic E. coli (UPEC) infections account for roughly 80% of all UTIs, causing 
cystitis in the bladder and acute pyelonephritis in the kidneys. UPEC has the challenge of 
moving from the intestinal tract to establish an infection in the urinary tract, where it uses 
peptides and amino acids as the primary carbon source for fitness (Alteri et al., 2009).The 
adhesin that has been most closely associated with Uropathogenic E. coli is the P fimbriae (or 
pyelonephritis-associated pilli [PAP]). The letter designation is derived from the ability of P 
fimbriae to bind specifically to the P blood group antigen which contains a D-galactose-D-
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galactose residue. The fimbriae bind not only to red cells but to a specific galactose 
dissaccharide that is found on the surfaces uroepithelial cells in approximately 99% of the 
population (Todar, 2008).  
 
2.3.8 NEONATAL MENINGITIS E. coli 
 
NMEC is a common inhabitant of the gastrointestinal tract and it is the most frequent cause 
of Gram-negative-associated meningitis in newborns. Fatality rates can approach 40% (Kaper 
et al., 2004), and survivors are usually burdened with severe neurological sequelae. The 
pathogenesis of NMEC is complex, as the bacteria must enter the bloodstream through the 
intestine and ultimately cross the blood–brain barrier into the central nervous system, which 
leads to meningeal inflammation and pleocytosis of the cerebrospinal fluid. The K-1 antigen 
is considered the major determinant of virulence among strains of E. coli that cause neonatal 
meningitis. K-1 is a homopolymer of sialic acid. It inhibits phagocytosis, complement, and 
responses from the host's immunological mechanisms. K-1 may not be the only determinant 
of virulence, however, as siderophore production and endotoxin are also likely to be involved 
(Todar, 2008).  
 
2.4 Epidemiology of E. coli 
 
The epidemiology of foodborne pathogenic E. coli varies throughout the world. In 
communities with poor sanitation and hygiene, enterotoxigenic E. coli (ETEC), 
enteroinvasive E. coli (EIEC) and enteropathogenic E. coli (EPEC) are prevalent (Wanke et 
al., 1991).  In developing countries, enterotoxigenic E. coli (ETEC) is the most recognized 
cause of infectious diarrhoea. Worldwide, the incidence of ETEC infections is estimated to 
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result in 650 million cases of diarrhoea and 380,000 deaths in children under the age of 5 
years. The pathogen is also an important cause of travelers’diarrhoea in persons traveling to 
endemic regions of the world (Okoh and Osode, 2008). The ease with which people move 
around the world has dramatically increased the frequency of traveler’s diarrhoea, which now 
affects up to one-third of individuals who visit developing areas, such as Africa, South Asia, 
Latin America, and the Middle East. Because ETEC has endemic and epidemic potentials, the 
pathogen is a major cause of relatively serious disease during natural disasters. They are 
acquired by consumption of contaminated food and water and by cross-contamination 
through direct human contact. Foodborne pathogenic E. coli have emerged paradoxically in 
communities with better developed sanitation and hygiene.  However, the pathotypes differ 
(e.g. STEC, EHEC and Enteroaggregative E. coli [EAggEC]) and the transmission pathways 
often include raw or inadequately processed animal or horticulture products, contact with 
animal manure, contaminated water and cross-contamination with raw food (Todar, 2008).  
Most E. coli strains pose no harm to human health, except for serotype O157:H7, which can 
cause food poisoning in humans and can become life-threatening (Karch et al., 2005). Other 
less common serotypes, such as O104:H4, O121, O26, O103, O111, O145, and O104:H21 
can also cause serious infection. EAEC and persistent diarrhoea syndrome have been 
consistently associated (Lima et al., 1992; Fang et al., 1995). The increasing number of such 
reports and the rising proportion of diarrheal cases in which EAEC are implicated suggest 
that EAEC are important emerging agents of paediatric diarrhoea. Humans can be infected by 
ingesting contaminated water, even though tap water contains chlorine and has undergone 
ozone or ultraviolet treatment; some E. coli outbreaks have been caused by contaminated 
municipal water supplies (Okoh and Osode, 2008). Private wells can be a source of infection, 
as can some lakes and swimming pools. Ingesting contaminated food, examples include 
ground beef, unpasteurized milk, or fresh vegetables (Bielaszweka et al., 2011. Infected 
23 
 
people who work in restaurants and do not wash their hands properly after going to the toilet 
can spread the infection to customers and other members of staff (Buso et al., 2013; 
unpublished data). Having physical contact with an infected person is known as person-to-
person contact. Good hand hygiene is important in stemming the spread of infection.  
Uropathogenic E. coli (UPEC) is responsible for approximately 90% of urinary tract 
infections (UTI) seen in individuals with ordinary anatomy (Todar, 2008).  In ascending 
infections, fecal bacteria colonize the urethra and spread up the urinary tract to the bladder as 
well as to the kidneys (causing pyelonephritis) Nicolle (2008) or the prostate in males. 
Because women have a shorter urethra than men, they are 14 times more likely to suffer from 
an ascending UTI (Todar, 2008). 
 
2.5 Clinical manifestations of different E. coli diseases 
 
Patients with E coli traveler's diarrhea (i.e., watery nonbloody diarrhea; caused by 
enterotoxigenic E coli [ETEC] or enteroaggregative E coli [EAggEC]) may appear to be 
dehydrated (Kaper and Nataro, 1998; Todar, 2008). Traveler's diarrhea is observed in young 
healthy travelers to tropical countries and is watery diarrhea without polymorphonuclear 
(PMN) leukocytes. The differential diagnoses of E coli traveler's diarrhea include rotavirus 
infection, Norwalk virus infection, Salmonella infection, and Campylobacter diarrhoea (Okoh 
and Osode, 2008).  
 
Patients with E coli childhood diarrhea (ie, watery nonbloody diarrhea; caused by EAggEC, 
enteroadherent E coli [EAEC], or enteropathogenic E coli [EPEC]) may also appear to be 
dehydrated. These infections produce a non-inflammatory watery diarrhea observed 
especially in children. The differential diagnoses of E coli childhood diarrhea include Vibrio 
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cholerae infection and Rotavirus infection. In May, June, and July, 2011 an outbreak of 
gastroenteritis caused by Shiga-toxin–producing E coli was seen in Germany (Bielaszweka et 
al., 2001). The majority of patients were adults and 22% of the cases developed hemolytic–
uremic syndrome, the outbreak strain was typed as an enteroaggregative Shiga-toxin–
producing E coli O104:H4, producing extended-spectrum beta-lactamase (Frank et al., 2011). 
The consumption of sprouts was identified as the most likely vehicle of infection. This 
outbreak was different as it was caused by EAggEC that produced a Shiga toxin and it 
exemplifies the threat posed by foodborne pathogens with their propensity to cause large 
common-source outbreaks (Frank et al., 2011; Buchholz et al., 2011).   
 
Patients with E coli dysentery (caused by enteroinvasive E coli [EIEC] or enterohemorrhagic 
E coli [EHEC]) have fever, bloody diarrhea, and dehydration. Intestinal mucosa produces a 
significant inflammatory response (Pennington, 2010). Clinically, patients with E coli 
dysentery present with fever and have blood and PMN leukocytes in their stool. The 
differential diagnoses of E coli dysentery include shigellosis and amebic dysentery. Patients 
with E coli HUS (caused by EHEC) have fever, bloody diarrhea, dehydration, hemolysis, 
thrombocytopenia, and uremia requiring dialysis. Symptoms of E coli HUS range from 
asymptomatic to non-bloody diarrhea to bloody diarrhea, renal failure, microangiopathic 
hemolytic anemia, thrombocytopenia, and CNS manifestations. The differential diagnoses of 
E coli HUS include Shigella infections, Clostridium difficile enterocolitis, ulcerative 
colitis/Crohn disease, ischemic colitis, diverticulosis, and appendicitis (Croxen and Finlay, 
2010). 
 
 
 
 
25 
 
 
2.6 Laboratory diagnosis 
 
2.6.1 Morphology and identification 
 
On MacConkey agar, deep red colonies are produced, as E. coli is lactose-positive, and 
fermentation of this sugar will cause the medium's pH to drop, leading to darkening of the 
medium. Growth on EMB agar produces black colonies with a greenish-black metallic sheen. 
This is diagnostic of E. coli (Okoh and Osode, 2008).On violet red bile mug agar selective 
medium a colour-change to red indicates lactose positive colonies like E. coli and other 
coliform organisms. E. coli can be demonstrated by fluorescence in the UV (Lues et al., 
2010). Light microscope will show Gram-negative rods, with no particular cell arrangement. 
The organism is also lysine positive, and grows on TSI slant with a (A/A/g+/H2S-) profile. 
IMViC is a battery of biochemical tests used in the clinical lab to distinguish between enteric 
microorganisms. The acronym IMViC stands for indole, methyl red, Voges- Proskauer and 
citrate. The "i" in the acronym is added for pronunciation purposes. IMViC is {+ + – -} for E. 
coli; as it is indole-positive (red ring) and methyl red-positive (bright red), but VP-negative 
(no change-colourless) and citrate-negative (no change-green colour) (Paton and Paton, 
1998). Oxidase Test is used to demonstrate the ability of a bacterium to produce the enzyme 
cytochrome- c oxidase, capable of reducing oxygen. Only Aerobic bacteria have this enzyme. 
A positive test will show a colour change to blue, then to dark purple or black, within 10 to 
30 seconds. E. coli is oxidase negative. 
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2.6.2 Serotyping 
 
Somatic and flagellar antigen determinations help to classify organisms into primary 
phenotypes. Such antigen determination is called serotyping (Todar, 2008). Serotyping is a 
subtyping method based on the immunologic characteristics of two surface structures, the 
lipopolysaccharide (LPS), which contains the O-antigen, and the flagella, which contains the 
H-antigen. The O-antigen is the outermost component of the LPS, an immunoglycolipid 
contained in the outer membrane of gram-negative bacteria. O-antigens are composed of 
multiple repeats of an oligosaccharide unit typically composed of four to six sugars. 
Variations in the composition, arrangement, and linkages of these sugars all contribute to O-
antigen diversity and are the basis for serotype diversity. The H-antigen is a part of the 
flagellar protein affecting motility. Identification of the H-antigen provides an additional tool 
for STEC surveillance and organism characterization, but H-antigen determination is not 
necessary for routine testing (Todar, 2008). Serotyping of E. coli, together with genome, 
virulence, and phage typing, is a useful epidemiological tool. 
 
2.6.3 Molecular characterization 
 
2.6.3.1 Polymerase Chain Reaction (PCR) 
 
PCR protocols targeting the genes of Escherichia coli provide a rapid and sensitive 
diagnostic tool to detect potentially virulent strains that have been isolated in culture from 
patient stool specimens (Vidal et al., 2004). Both conventional and real-time PCR methods 
provide a satisfactory detection limit for identifying Shiga toxin-producing organisms. The 
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selection of a specific methodology will depend on individual laboratory preference, 
acceptable timelines, available funding and the experience level of laboratory staff 
(Velusamy et al., 2007). Conventional PCR is a molecular testing option for laboratories that 
do not have real-time PCR instrumentation. This methodology requires the use of a 
conventional, or block, thermal cycler and resolution of the PCR products using agarose gel 
electrophoresis (Lang et al., 1994). 
 
2.6.3.2 Pulse Field Gel Electrophoresis (PFGE) 
 
In recent years, the use of molecular ―fingerprinting‖ methods has become standard practice 
in microbiology for evaluating the epidemiology of infectious diseases, investigating 
suspected outbreaks of bacterial infections, and typing bacteria (Mickelsen, 1997). Pulsed-
field gel electrophoresis (PFGE) allows the generation of simplified chromosomal restriction 
fragment patterns without having to resort to probe hybridization methods. In this method, 
restriction enzymes that in frequently cut DNA are used for generating large fragments of 
chromosomal DNA, which are then separated by special electrophoresis (Swaminatham and 
Matar, 1993). PFGE has been applied to subtyping of several gram-positive and gram-
negative bacteria. PFGE may be used for genotyping or genetic fingerprinting. It is 
commonly considered a gold standard in epidemiological studies of pathogenic organisms 
(Schwartz and Cantor, 1984). The preparation of genomic DNA suitable for PFGE begins by 
lysing bacteria that are encased in agarose blocks. After multiple washes, the DNA within the 
agarose is digested with restriction enzymes and electrophoresed using PFGE. PFGE differs 
from conventional agarose electrophoresis in that it takes longer because the orientation of 
the electric field across the gel is periodically changed in contrast to being unidirectional and 
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constant in standard electrophoresis. The variability in the electric field allows PFGE to 
resolve the very large fragments (>600 kb) associated with this analysis (Goering, 2004). 
 
2.7 E. coli outbreaks from raw milk and dairy products 
 
Raw milk has been implicated as the vehicle of sporadic cases and several outbreaks of 
EHEC-associated illness in North America, Europe, and Malaysia (Murinda et al., 2002; 
Chye et al., 2004 and Murphy et al., 2005).  While cows’ milk is the most common source, 
goats’ and sheep milk has been implicated in E. coli O157 infection. Although EHEC and 
STEC are the most studied pathogenic E. coli in farm environments, other types (EAEC and 
EPEC) have been detected (Singh et al., 1970). Cheese has been the attributed vehicle in 
several EHEC outbreaks. Outbreaks of E. coli O157:H7 have been attributed to a variety of 
cheeses such as farm produced cheese, fresh cheese curds, a semi hard Lancashire cheese, 
and Gouda made from unpasteurized milk (Vivegnis et al., 1999). Other serotypes have 
included EHEC O103:H2 contaminating soft cheese made from a mixture of unpasteurized 
cows’ and goats’ milks; O119 EHEC in fromage frais; and O26 EHEC from a raw milk 
Camembert cheese in France (Vernozy-Rozand et al., 2005). The use of contaminated raw 
milk or postprocessing contact with raw milk and subsequent survival of the EHEC during 
the cheesemaking process have been the major contributing factors. 
 
2.8 Common E. coli virulence genes isolated from raw milk 
  
Enterohemorrhagic Escherichia coli (EHEC) strains are a subset of Shiga toxin (Stx)-
producing E. coli (STEC) strains that are isolated from human patients and are responsible 
for severe clinical symptoms, including diarrhoea, hemorrhagic colitis, and hemolytic-uremic 
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syndrome. These diseases are directly related to the virulence genes present in the causative 
agent (Betteheim, 2000; Elliot et al., 2001). Four of the most commonly assayed virulence 
factors of STEC are the two phage encoded cytotoxins, called Shiga toxin 1 and 2 (encoded 
by the Stx1 and Stx2 genes, respectively), the protein intimin (encoded by the chromosomal 
gene eae), which is responsible for the intimate attachment of the bacteria to intestinal 
epithelial cells, and the plasmid-encoded enterohaemolysin, also called enterohaemorrhagic 
E. coli haemolysin (EHEC-HlyA), encoded by the ehxA gene (Law, 2000; Gyles, 2007). 
Shiga toxin-producing E. coli can be transmitted through different routes, including food and 
water, person-to-person contact, and animal-to-person contact. Most human infections are 
caused by consumption of contaminated food. Domestic animals and wild ruminants, in 
particular cattle, are considered the main reservoir of STEC and the main source of 
contamination of the food supply (Caprioli et al., 2007; Erickson and Doyle, 2007). The 
presumed route of E. coli contamination of raw milk is via faecal contamination during 
milking (Hussein and Sakuma, 2005). However, direct excretion of the organisms from the 
infected udder has also been reported (Lira et al., 2004). 
 
2.9 Antibiotic resistance in bacteria 
 
2.9.1 Antibiotics 
 
Antibiotics are a group of natural microbial products or synthetic chemical compounds that 
inhibit the growth of and even kill bacteria (Prescott et al., 1996). Natural antibiotics are 
produced by both bacteria or fungi and act by blocking some essential cell processes in other 
bacteria. The first natural antibiotic isolated in pure form was penicillin and it came into 
clinical practice in the 1940s.Synthetic chemical compounds are man-made and also target  
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some of the vital cell mechanisms in bacteria. In addition, another category of antibiotics, i.e. 
semi-synthetic antibiotics, are the chemically modified form of the natural antibiotics to 
enhance the effectiveness of natural antibiotics (e.g. ampicillin and methicillin). Antibiotics 
are grouped into different classes (Table 1) based on their chemical structures: such as ß-
lactams, aminoglycosides, macrolides, ketolides, tetracyclines, glycopeptides and others, and 
based on their mode of actions: such as inhibitors of bacterial cell wall synthesis, inhibitors of 
protein synthesis, disruptors of cell membranes and inhibitors of nucleic acid synthesis 
(Walsh, 2003). Beta-lactams (penicillins, cephalosporins, cephamycins, monobactams, and 
carbapenems), glycopeptides and other antibiotics inhibit the biosynthesis of peptidoglycan, a 
rigid polymer in cell wall that resists a high osmotic pressure inside the cell. In contrast, 
aminoglycosides and tetracyclines complexes with the conserved sequences of the 16S rRNA 
of the 30S ribosomal subunit while macrolides, ketolides, lincosamides and chloramphenicol 
bind to the sequences of the 23S rRNA of the 50S ribosomal unit thus affecting the protein 
biosynthesis (Mascaretti, 2003). Antibiotics like fluroquinolones act on deoxyribonucleic 
acid (DNA) gyrase and topoisomerase IV and prevent synthesis of DNA and ribonucleic acid 
(RNA). On the other hand, sulfonamides (for example sulfamethoxazole) and trimethoprim 
interferes in the folic acid metabolism in bacteria that indirectly affects the nucleic acid 
synthesis. Sulfamethoxazole blocks the enzyme dihydropteroate synthase in folic acid 
synthesis while trimethoprim inhibits the enzyme dihydrofolate reductase that supplies the 
pyridime thymidylate for the DNA biosynthesis (Walsh, 2003). 
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   Table 2.1: Antibiotics used in the treatment of E. coli infection. 
  
Major antibiotics grouped according to their mechanisms of action and their chemical 
structures (Levy and Marshall, 2004). 
 
2.9.2 Antibiotic resistance in E. coli 
 
Soon after the introduction of penicillin in clinical practices in the 1940s followed by other 
antibiotics thereafter, antibiotics were virtually effective against pathogenic bacteria. 
However, the effectiveness of the antibiotics was greatly reduced due to the use and misuse 
of antibiotics (Walsh, 2003; Aminov, 2009). Several new antibiotics, targeting essential 
physiological or metabolic functions of the bacterial cell, were introduced in the last several 
decades but bacteria responded each time by evolving themselves as resistant strains 
(Barbosa and Levy, 2000; Levy and Marshall, 2004). 
 
In the context of food-animal production systems, mastitis is the most common and most 
economically significant disease affecting dairy cattle.  
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It is the leading cause of antimicrobial use on dairy farms (Saini et al., 2012). Antimicrobial 
therapy is commonly implemented for mastitis prevention and control. Unfortunately, despite 
the best possible antimicrobial treatments, failures of bacteriological cure are common, and 
antimicrobial resistance (AMR) is considered one of the reasons for low cure rates (Barkema 
et al., 2006).  Bacterial infections are usually treated with antibiotics. However, the antibiotic 
sensitivities of different strains of E. coli vary widely. As Gram-negative organisms, E. coli 
are resistant to many antibiotics that are effective against Gram-positive organisms.  
Antibiotics which may be used to treat E. coli infection include amoxicillin, as well as other 
semisynthetic penicillins, many cephalosporins, carbapenems, aztreonam, trimethoprim-
sulfamethoxazole, ciprofloxacin, nitrofurantoin and the aminoglycosides (Johnson et al., 
2006). Several factors have been implicated for the emergence of the antibiotic-resistant 
bacteria and their spreading in the environment. In general, there is a consensus that the 
increased use of antibiotics is the prime factor for the increased resistance in pathogenic 
bacteria (Levy and Marshall, 2004). Not only the antibiotic use in human medicine has been 
linked to the elevated antibiotic resistance in bacteria, the use of antibiotics in veterinary 
medicine, agriculture, aquaculture, horticulture and other human activities have been 
identified as the other driving forces in escalating the problem (Aarestrup, 1999; Barbosa and 
Levy, 2000; Aminov, 2009). The antibiotics are used for food animal production in one of the 
following situations: treatment of infectious diseases, metaphylactics, prophylactis, and 
growth promotion (Aarestrup, 2005). Quantity as much as half of the total antibiotics 
produced worldwide is used for food animal production, primarily as growth promoter and 
prophylactic agents (Aarestrup, 1999). Although the use of antibiotics as growth promotion 
has been banned in the European Union (EU), however, it is being continuously used in other 
parts of the world (Levy and Marshall, 2004). This selective pressure on the environment is 
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not insignificant for the development of antibiotic resistance in enteric bacteria in animals, 
considering the fact that animals frequently harbor human pathogens in their intestinal tract 
such as Salmonella, Campylobacter, Yersinia, Listeria and enterohaemorrhagic E. coli 
(Aarestrup 1999; Levy and Marshall, 2004).  
 
A bacterial strain is defined as resistant strain to an antibiotic when the strain is able to grow 
at the lowest concentration of the antibiotic that usually inhibits the growth of the wild strain 
belonging to the same species. This lowest concentration of the antibiotic that effectively 
prevents the growth of a particular strain is called minimum inhibitory concentration (MIC). 
The antibiotic resistance may be either intrinsic or acquired resistance. The intrinsic 
resistance is caused by structural or functional characteristics inherited to a bacterial group 
(that includes species, genus or even to a higher level) such as the low affinity of the 
antibiotics to the target, the inability of the antibiotics to enter the bacterial cell, removal of 
the antibiotics from the cell by chromosomally encoded active exporters, inactivation of 
antibiotics by innate enzymes and other mechanisms (Guardabassi and Courvalin, 2006). 
Unlike intrinsic resistance, the acquired resistance is inherited to only some strains of a 
particular genus or species. However, the acquired resistance possesses a serious problem as 
it causes the emergence and spread of resistance to the usually susceptible bacteria. This 
mobile nature of acquired resistance can easily disseminate among bacteria of 
morphologically and ecologically distinct groups (horizontal transfer) through mobile genetic 
elements such as bacteriophages, plasmids, naked DNA or transposons. In addition, mutation 
on genetic elements can also enable bacteria to acquire the resistance to a particular antibiotic 
(Levy and Marshall, 2004). The process of acquisition of resistance genes can be through 
transduction in which bacteriophages mediates the transfer of DNA having resistant 
determinants into the host cell or the transformation which involves the uptake of plasmids or 
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naked DNA from the environment. Another important process of acquiring resistance is the 
conjugation that is the transfer of plasmids or chromosomal DNA by cell-to-cell contact. The 
conjugation has been regarded as by far the most important mechanism in spreading the 
antibiotic resistance, even between distinct taxonomic and ecological groups of bacteria 
(Barbosa and Levy, 2000). The horizontally transferable plasmids that contain some specific 
genetic structures such as complex transposons or integrons enhance the distribution of 
resistance genes between bacteria (Walsh and Fanning, 2008). 
 
2.9.3 Mechanisms of bacterial antibiotic resistance 
 
Several mechanisms have been proposed by which bacteria evolved to overcome the 
detrimental effects of antibiotics in the surrounding environment. The bacteria may restrict 
the entry of antibiotics by modifying the cell membrane composition, by reducing the uptake 
or exporting the antibiotics from the cell by active-efflux. In addition, alteration of the 
antibiotics by cellular enzymes may be another way of getting resistance to antibiotics. The 
bacterial cell may also respond by altering the affinity of the antibiotics to the target or by 
overexpression of the target (Mascaretti, 2003). Inactivation of antibiotics by enzymes is the 
main mechanism of resistance to β-lactams, aminoglycosides, and phenicols. Β-lactamases 
are the most important drug-inactivating enzymes that hydrolyze the β-lactam ring of 
penicillins, cephalosporins and carbapenems. On the other hand, the aminoglycoside-altering 
enzymes interfere catalyze the transfer reaction that restricts the binding of the antibiotic to 
ribosomes. However, enzymatic destruction of antibiotics has not been observed in the 
synthetic class of antibiotics: the sulfamethoxazole-trimethoprim, the fluroquinolones or the 
oxazolidines (Walsh, 2003). Specific-drug-resistance (SDR) efflux pumps are the primary 
mechanism of resistance against tetracyclines, other multiple-drug-resistance (MDR) pumps 
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play important roles for the multiple resistance against antimicrobials such as β-lactams, 
macrolides and fluoroquinolones (Walsh, 2003; Guardabassi and Courvalin, 2006). Multidrug 
resistance can be acquired by bacteria through accumulation of genes in R plasmids or 
transposons that encode resistance to specific antibiotics and/or by the MDR pumps that can 
export more than single drug type (Nikaido, 2009). This R plasmid with multidrug resistance 
genes may be transferred to another bacterial species quickly either by conjugation, 
transformation or transduction and hence the new species can be resistant to several 
antibiotics. In this way, the pathogenic bacteria can become multidrug resistance (Mascaretti, 
2003). 
 
2.9.4 Antibiotic resistance in food-related bacteria 
 
The role of the food chain as a source of antimicrobial-resistant pathogens, including 
Salmonella, E. coli and Campylobacter, is of significant consequences to the public health 
(Mølbak, 2004). The use of antibiotics in food animals production, such as for growth 
promotion and prophylactic reason, is of significant importance for the increased resistance in 
zoonotic bacteria such as Salmonella, Campylobacter, Listeria, enterohaemorrhagic E. coli 
(Aarestrup, 1999; Sørum and L’Abée-Lund, 2002; Levy and Marshall, 2004). The antibiotics 
used in animal husbandry are also of great significance as many of these antibiotics are used 
in the human medicine and the resultant antibiotic-resistant bacteria can spread the resistance 
phenomenon worldwide through the global trade of animal foods (Aarestrup et al., 2008). 
Similarly, commensal bacteria that interact with zoonotic bacteria through the food chain are 
also of increased concern as these bacteria might act as reservoirs of antibiotic resistance 
genes that can be transferrable to pathogenic bacteria of humans (van den Bogaard et al., 
2000; Wang et al., 2006; Hawkey and Jones, 2009). The agricultural practices provide a 
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significant impact on the dissemination of antibiotic resistance elements in the environment, 
including the use of antibiotics in the fruits and vegetables production. The application of 
antibiotics in animal husbandry and the subsequent isolation of the antibiotic-resistant 
bacteria in the production chain suggest, in many cases, a direct relationship while it may not 
be the case when the reduced use of antibiotics in organic farming brings the reduction of the 
antibiotic resistance on the pathogenic bacteria (Wright, 2010). 
 
In the growing concern of antibiotic resistance in food-related bacteria, more and more 
studies were undertaken in recent years to assess the antibiotic resistance of bacteria isolated 
from food products such as raw milk (Citak et al., 2005; Straley et al., 2006; Munsch-
Alatossava and Alatossava, 2007), cheese (Valenzuela et al., 2009), raw vegetables (Boehme 
et al., 2004), ground meat products (White et al., 2001) and poultry (Sackey et al., 2001). The 
majority of these studies were focused on assessing the prevalence of antibiotic resistance in 
enteric bacteria; however few of them also considered non-enteric bacteria. In a study on the 
prevalence of antibiotic-resistant bacteria in vegetables and seed sprouts, Boehme et al. 
(2004) reported that the antibiotic-resistant bacteria as high as 108 CFU/g, were observed in 
seed sprouts and many of these isolates were multidrug-resistant. Compared with seed 
sprouts the common vegetables were less contaminated with antibiotic-resistant bacteria. 
Like Sackey et al., (2001) reporting on the prevalence of multiresistant enteropathogenic 
bacteria in poultry in Ghana, a widespread multidrug resistance has been reported in E. coli 
and Salmonella isolated from retail raw chicken products in Japan; 40.6% of 69 E. coli 
isolates and all 10 Salmonella isolates studied were multidrug-resistant (Ahmed et al., 2009). 
These isolates showed multidrug resistance against antibiotics such as ampicillin, 
streptomycin, spectinomycin, kanamycin, tetracycline, trimethoprim-sulfamethoxazole, 
nalidixic acid, cefoperazone, cephalothin, cefoxitin, and ciprofloxacin. The authors concluded 
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that the retail chicken meat could be of significant importance in spreading the multidrug-
resistant bacteria. 
 
2.9.5 Antibiotic resistance of raw milk-associated bacteria 
 
The raw milk-associated bacteria have shown various levels of resistance against many 
antibiotics of clinical significance. Although many studies focused on pathogens in raw milk 
of public health significance, however, few studies also considered antibiotic resistance on 
raw milk associated other bacteria. Bulk tank milk (BTM) was used to monitor the 
antimicrobial resistance in dairy farms and suggested that the monitoring of the antimicrobial 
resistance of E. coli in bulk milk can reasonably provide the overview of antimicrobials use 
in the farm (Berge et al., 2007). The prevalence of multidrug resistant E. coli and Salmonella 
in BTM was reported being 23%; the frequency of isolating E. coli was more frequent than 
Salmonella. Citak et al. (2005) studied the antibiotic resistance of enterococci isolated from 
raw milk and reported that the predominant enterococci were E. faecalis (54.2%) and E. 
faecium (29.0%). These isolates demonstrated extensive resistance to antibiotics such as 
ampicillin, ciprofloxacin, erythromycin, gentamicin, imipenem, streptomycin, tetracycline 
and vancomycin. Similarly, enterococci isolated from the raw cow’s milk and cheeses 
derived from such milk showed resistance against many antibiotics such as ciprofloxacin, 
levofloxacin, erythromycin, tetracycline but all were sensitive to ampicillin, chloramphenicol 
and gentamicin (Valenzuela et al., 2009). 
 
The prevalence of Gram-negative bacteria in bulk tank milk was studied by Straley et al. 
(2006). Among 54 bulk tank milk samples (obtained from six farms for a period of nine 
months) analysed, 46 (85%) of the samples were positive for Gram-negative bacteria. The 
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amount of these bacteria in bulk tank milk varied widely among farms (12-1310 CFU/mL) 
and Pseudomonas spp. were the dominant non-coliform Gram-negative bacteria that showed 
extensive resistance to antibiotics considered in the study. The antibiotic-resistant 
Pseudomonas spp. are of significant importance in dairy industries because they grow at low 
temperature and have the potential of forming biofilms in the bulk tank. In addition, other 
Gram-negative bacteria detected in this study were belonging to the genera Acinetobacter, 
Citrobacter, Enterobacter, and to E. coli. These bacteria were resistant to first, second and 
third generation of cephalosporins but were susceptible to fourth generation of 
cephalosporins, fluoroquinolones (enroflaxacin) and aminoglycosides (gentamicin). This 
study suggested that bulk tank milk could be a major source of antimicrobial-resistant Gram-
negative bacteria (Straley et al., 2006). 
 
2.10 Prevention of mastitis 
 
2.10.1 Management aspects 
 
The key elements in the control of mastitis include sound husbandry practices and sanitation, 
post-milking, teat dipping, treatment of mastitis during non-lactating period, and culling of 
chronically infected animals. Dry animal therapy can eliminate 70% of environmental 
streptococcal infections. The fundamental principle of mastitis control is that the disease is 
controlled by either decreasing the exposure of the teat to potential pathogens or by 
increasing resistance of dairy animals to infection. Jones (2006) has suggested approaching 
the treatment in the same way a surgeon approaches surgery. Wash hands with soap and 
water, wash teats and udder in sanitizing solution, thoroughly dry teats and udder with 
individual towels, dip teats in an effective germicidal teat dip. Allow 30 seconds of contact 
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time before wiping off teat dip with an individual towel; thoroughly scrub the teat end with a 
cotton swab soaked in alcohol. If all four quarters are being treated, start by cleaning the teat 
farthest from you and work toward the closest teat, use commercial antibiotic products in 
single dose containers formulated for intramammary infusion. Treat teats nearest to you first, 
then those farthest away to prevent contaminating clean teat ends. Dip teats in an effective 
germicidal teat dip after treatment (Sharif and Muhhamad, 2009).Before permitting supply of 
products made from unpasteurized milk, it is necessary to investigate potential hazards to 
public health and recommend control strategies to mitigate them. Nationwide control 
programmes have successfully eliminated or greatly reduced the risk of historic pathogens 
such as brucellosis or tuberculosis entering human milk supply. But product from cows, 
sheep or goats still cannot be guaranteed free from other pathogens, even when produced 
under hygienic conditions, because of fecal contamination or direct excretion into the milk 
(Rampling, 1996). Additionally potential risk factors for bacteria in milk and on-farm control 
measures to reduce risk must be reviewed and recommendations given to minimize these 
risks. 
 
2.10.2 Vaccination 
 
Prophylactic immunization is used in some countries to prevent coliform mastitis. Vaccines 
developed using the common core antigen of coliform bacteria, administered systemically at 
drying-off and again 3 weeks before the calving date, have been in use in North America for 
many years (Hogan et al., 1992; Wilson and González, 2003; Wilson et al., 2007a). 
Vaccination is able to reduce the severity of clinical signs and protect cows from culling or 
death and to reduce the milk loss. However, the incidence of clinical mastitis has not been 
reduced (Wilson et al., 2007a; Wilson et al., 2007b). In some earlier studies, a reduced risk 
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for clinical mastitis in vaccinated cows was reported (Cullor, 1991; Hogan et al., 1992). In 
addition to the common core antigen, iron regulated outer-membrane protein vaccines against 
coliform mastitis have also been investigated (Lin et al., 1999). 
 
2.10.3 Genetic engineering in improving mastitis 
 
Genetic engineering is one tool suggested to increase host defense against mastitis (Bramley 
et al., 2001; Maga et al., 2005; Pyörälä, 2002 ). Increasing mastitis resistance by improving 
the immune response through modifying activity of genes or incorporating beneficial genes 
from other organisms has been proposed to have a positive impact on cow welfare and 
economics of milk production (Oliver, 2005). The transgenic approach to enhance mastitis 
resistance was studied in a mouse model (Kerr et al., 2001). In the first published cow model 
(Wall et al., 2005), cows carrying a gene coding for an anti-staphylococcal peptide, 
lysostaphin, were shown to resist S. aureus intramammary infection. The first transgenic 
cows with the hLf gene were reported to express Lf in their milk at a concentration of 0.3 to 
2.8 mg/ml (Brink et al., 2000; Van Berkel et al., 2002). A gene encoding human lactoferrin 
(hLf) in the bovine mammary gland could be a good candidate to increase resistance of dairy 
cows to coliform mastitis by transgenesis. 
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CHAPTER THREE  
Prevalence of Escherichia coli in raw milk from two dairy farms of the Eastern Cape, 
South Africa 
 
ABSTRACT 
 
Milk quality continues to be a topic of intense debate in the dairy industry, medical and 
public health communities. Production of maximum quantities of high-quality milk is an 
important goal of every dairy operation. High-quality milk must contain a low number of 
somatic cells and low bacteria count, and must be free of human pathogens and antibiotic 
residues. The objective of this study was to determine the prevalence of E. coli in 
unpasteurized milk recovered from Middledrift and Fort Hare dairy. In this study 400 milk 
samples were collected from two commercial farms (Middledrift and Fort Hare) in the 
Eastern Cape, South Africa, 200 raw milk samples from each farm. Samples were cultured on 
violet red bile mug-agar (VRB-MUG Agar) and incubated at 37ºC for 24 hours and 
preliminary identified by Gram stain and catalase test. Isolates that were Gram negative and 
catalase positive were screened for a marker of E. coli uidA gene using PCR assays. 
Middledrift dairy farm had 50 (25%)  E. coli isolated from raw milk and Fort Hare farm 
showed 37 (18.5%) E. coli present in the milk samples. The presence of E. coli found in the 
milk samples points to the fact that fecal contamination was unavoidable and traditional 
practices are likely to contribute to the contamination of the milk and proliferation of the 
microorganisms. 
 
Keywords: Raw Milk, Escherichia coli, Polymerase Chain Reaction (PCR). 
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3.1 INTRODUCTION  
 
Milk being a major constituent of the diet, quality control of milk is considered essential to 
the health and welfare of a community. However, people from rural areas show very little 
interest as to whether food and drink are good or detrimental to their health; their only 
concern is on buying enough food to keep them from starvation (Fox and Cameron, 1995; 
Lues et al., 2010). In developed societies, practices generally used to curb microbial 
proliferation in milk include pasteurization and refrigeration. People from rural areas, 
however, do not utilize such practices mainly due to lack of infrastructure and funds (Rohde, 
1985; Collins et al., 1995). Milk has distinct physical, chemical and biological characteristics 
and its colour, odour, taste, consistency, freezing point (- 0.55°C), pH (6.6) and specific 
gravity (1,032) are characteristics that remain particularly constant (Abdullah et al., 2009). 
These characteristics present a favourable environment for the multiplication of several 
bacteria of various genera. Generally, bacteria in the milk can occur through colonization of 
the teat canal or an infected udder (clinical and subclinical mastitis) or gets contaminated at 
various stages be it from the animal, milker (manual as well as automated), extraneous dirt or 
unclean process water (Stewart, 1978; Rohde, 1985; Banwart, 1989; Philips & Griffiths, 
1990; Gruetzmacher & Bradley, 1999; Hayes et al., 2001; Among all microorganisms 
Escherichia coli is the frequently contaminating organism, and is a reliable indicator of fecal 
pollution generally in insanitary conditions of water, food, milk and other dairy products 
(Diliello, 1982; Asmahan and Warda, 2011). E. coli is an environmental pathogen found in 
the immediate surroundings of the cow such as the soil, grass, manure and the bedding of 
housed cows. It is therefore easy for the organism to be found in the udder of cow thereby 
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gaining entrance to the milk. Its status as a true pathogen is of public health significance. It 
produces toxins that destroy cell membrane and can directly damage milk-producing tissues 
which can lead to bovine mastitis (Jones et al., 1998). It therefore became the objective of 
this study to determine the prevalence of E. coli in unpasteurized milk recovered from 
Middledrift and Fort Hare dairy farms. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Study Sites 
 
Eastern Cape Province is one of the poorest and second largest provinces in South Africa and 
mainly comprised of rural settlements, it is also the "livestock" province of the country and is 
home to 21% of South Africa's cattle, 28% of sheep and 46% of goats. Fort Hare dairy has 
been in operation since 2007, it has 800 dairy cows and produces about 10 000 L of milk per 
day which is bought by Clover SA, one of the biggest milk companies in South Africa. While 
Middledrift dairy farm has been in operation since 2008, it has 600 dairy cows and produces 
about 8 000 L of milk per day (http://www.amadlelo.co.za). Fort Hare dairy has a rotary 
milking parlour whereas Middledrift dairy has an in line milking system. Fort Hare dairy is 
located in the Eastern Cape Province in Alice with geographic coordinates of 32°46′59″ 
South and 26°49′59″ East. Middledrift dairy is also located in the Eastern Cape Province with 
geographic coordinates of 32° 49' 0" South, 26° 59' 0" East. 
 
3.2.2 Sampling and pH measurement 
 
Four hundred samples were collected; 200 samples from each of the two commercial farms, 
Middledrift dairy and Fort Hare dairy Trust. Samples were collected in sterile 50 ml 
66 
 
containers and transported to the University of Fort Hare microbiology laboratory on ice in a 
cooler bag. The pH of the milk was immediately measured using a pH meter in the 
laboratory. 
3.2.3 Isolation and identification 
 
For the isolation and identification of E. coli, the samples were cultured on selective medium 
Violet red bile - mug agar (VRBMA, Merck, RSA) and incubated at 37 °C for 24 hours 
(Chirsten et al., 1993; Houghtby et al., 1993). The plates were checked under UV light at 
about 360-370 nm after 24 hours of incubation. Light blue fluorescence indicates the 
presence of E. coli. Biochemical tests including Gram staining, catalase test and API 20E 
were performed to preliminary identify E. coli.  
 
Gram stain was done according to the method of Gram, (1884) by heat fixing a single colony 
on a microscopic slide and covering the slide with crystal violet for 20 seconds and then 
rinsing it off with water. After rinsing with water, Gram’s iodine was flooded for 1 minute 
and then poured off with 95% ethanol. The slide was then rinsed with water and covered with 
safranin for 20 seconds. Lastly it was rinsed with water and air dried and afterwards it was 
ready for observation under the light microscope. 
 
Catalase test was done by placing a single colony onto a microscope slide and 3% hydrogen 
peroxide was added. After 30 seconds if bubbles formed the test was positive and if not the 
test was negative (WHO, 1998). API 20 E was done following the manufacturer’s 
instructions. 
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3.2.4 DNA extraction 
  
DNA was extracted from identified E. coli isolates and from a positive control strains for E. 
coli (ATCC 8739) (SABS No ESC 20) purchased from the South African Bureau of 
Standards (SABS), Pretoria, South Africa. The extraction was done following the method of 
Maugeri et al. (2004) and Torres et al. (2003). Single colonies of presumptive E. coli grown 
overnight at 37 
oC on EMBA plates were picked, suspended in 200 μl of sterile distilled 
water, vortexed using a Minishaker (Digisystem laboratory instruments INC, Taiwan) and the 
cells were lysed using a Dri-Block DB.2A (Techne, SA) for 15 min at 100 ºC. The cell debris 
was removed by centrifugation at 10 000 rpm for 5 minutes using a MiniSpin microcentrifuge 
(ThermoFisher Scientific, Germany) to remove any particulate material that might still be 
present after processing. The lysate supernatant was placed on ice for 5 min. The supernatant 
was used as a template in the PCR assay immediately after extraction. 
 
3.2.5 Molecular characterization of E. coli 
  
Oligonucleotide primers targeting the uidA gene (147 bp) were used in the polymerase chain 
reaction with the conditions as shown in Table 3.1. The reaction mixture for running PCR 
contained 12.5 μl of 2X PCR master mix (0.05 units/μl Taq DNA polymerase in reaction 
buffer, 4 mM MgCl2, 0.4 mM dATP, 0.4 mM dCTP, 0.4 mM dGTP and 0.4 mM dTTP) 
(Thermo Scientific , SA), Nuclease free water (6.5 μl) (Thermo Scientific, SA), the cell 
lysates (5 μl) and 0.5 μl of the forward and reverse primer. PCR assay was carried out in a 25 
μl reaction volume. 
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3.2.6 Gel electrophoresis  
 
The PCR products (10 μl aliquots) were resolved in 1.8 % agarose gel containing 5 μl 
Ethidium bromide in 1X TBE buffer (40 mM Tris–HCl, 20 mM Naacetate, 1 mM EDTA, pH 
8) (Cagney et al., 2004; Wang et al., 2002) before being visualized and photographed under 
the Alliance System. A 100-bp DNA ladder was included on each gel as a molecular size 
standard. The electrophoresis was carried out at 100 V for 1 hour. 
 
Table 3.1-Primer sequences and expected size of PCR-amplified gene targets of the 
pathogenic strains of Escherichia coli. 
 
Target 
strain  
Target 
gene 
Primer sequence (5’-3’) Conditions Amplicon 
size (bp) 
Reference 
E.coli uidA AAAACGGCAAGAAA
AAGCAG 
 
ACGCGTGGTTAACAG
TCTTGCG 
2minutes denaturation at 
94
0
C followed by 25 
cycles of denaturation 
94
0
C for 1 minute, 58
0
C 
annealing for 1 minute and 
72
0
C extension for 2 
minutes. Amplified 
products were held at 4
0
C 
after amplification of 
cycles 
147 Tsai et al., 
1993 
3.3 RESULTS 
 
3.3.1 Biochemical characterization of E. coli 
 
Gram negative rods in Middledrift dairy samples were 100 (50%) and 88 (44%) in Fort Hare 
farm. One hundred (50%) of the samples were catalase positive from both farms. In 
Middledfift dairy 72 (36%) E. coli were identified by API 20E and in Fort Hare dairy 68 
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(34%) E. coli were identified by API 20E. Species identity by API ranged from 76.8% to 
99.9% in Middledrift and 76.8% to 100% in Fort Hare dairy (Appendix). 
 
3.3.2 Molecular identification of E. coli 
 
Isolates that were Gram negative and catalase positive were screened for a marker of E. coli 
uidA gene using PCR assays. Middledrift dairy farm had 50 (25%)  E. coli isolated from raw 
milk and Fort Hare farm showed 37 (18.5%) E. coli present in the milk samples (Figure 3.1). 
 
LL1 12 2 3 4 5 6 7 8 9 10 11 12  
 
  
Figure 3.1-Amplification product from the primer pair of the uidA gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024 and Lane 12: 1415. 
The expected molecular size of uidA fragments was 147 bp. 
 
L1     1      2      3      4       5     6      7     8      9     10    11   12 
100  
147 bp 
200  
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3.4 Discussion 
 
Nowadays, public health concern associated with microbial food safety has risen. The 
bacterium E. coli is one of the best and most thoroughly studied free-living organisms. It is 
also a remarkably diverse species because some E. coli strains live as harmless commensals 
in animal intestines. E. coli is a widely used indicator of fecal contamination in water bodies. 
External contact and subsequent ingestion of bacteria from fecal contamination can cause 
detrimental health effects (Meng et al., 2007). As E. coli is an indicator organism its recovery 
from milk suggests that other organisms of faecal origin including pathogens may also be 
present (Christen et al., 1992). Stomach cramps, nausea and vomiting are the symptoms 
caused by E. coli; however serious complications can also occur (Todar, 2008). E. coli is also 
a known causative agent of diarrhea and other foodborne-related illnesses through the 
ingestion of contaminated foodstuffs. Dairy cattle are considered the primary reservoir of 
pathogenic E .coli and the main route of E. coli infections in humans is via consumption of 
contaminated food (Hussein and Sakuma, 2005; Meng et al., 2007).  
 
Not all the isolates that produced a blue fluorescence colour under 300nm UV light on VRB-
MUG agar and were Gram-negative rods were identified as E. coli. This implies that VRB-
MUG agar is not a good selective media as other organisms producing a blue fluorescent 
colour like Enterobacter cloacae were also identified. Gram negative rods in Middledrift 
dairy samples were 100 (50%) and 88 (44%) in Fort Hare farm. One hundred (50%) of the 
samples were catalase positive from both farms.  In Middledfift dairy 72 (36%) E. coli were 
identified by API 20E and in Fort Hare dairy 68 (34%) E. coli were identified by API 20E. 
Species identity by API ranged from 76.8% to 99.9% in Middledrift and 76.8% to 100% in 
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Fort Hare dairy. The presence of Enterobacter spp, Klebsiella spp, Citrobacter spp and 
Salmonella spp identified by API 20E from the raw milk samples could render milk unfit for 
human consumption, since sufficient number of these organisms could cause infection and 
intoxication (Stephan et al., 2008). 
 
Raw milk can be easily contaminated by infected food handlers who practice poor personal 
hygiene or by water containing human discharges.  Globally, higher percentage of E. coli was 
reported by many authors including Egypt where the presence of coliform bacteria in raw 
milk was shown (Aly and Galal, 2002), India the raw milk and products were heavily 
contaminated by E. coli (Soomro et al., 2002),  South Africa where a higher percentage 
(51.3%) of E. coli in raw milk was detected (Lues et al., 2010), however Malaysia indicated 
that 90% of the examined raw milk was contaminated by coliform bacteria and 65% were E. 
coli positive (Chye et al., 2004) a figure higher than in our study. In Saudi Arabia, Altahali 
and Hassan (2009) recorded 60% of coliforms as the main contaminants of raw milk.  
 
 3.5 Conclusion and Recommendations 
 
The results obtained in this study suggest that high and strict preventive measures like regular 
washing and sterilization of dairy equipment, utensils, milker's hands, and animal udders, and 
eradication of diseased animals from the herd are highly recommended.  
 
 
 
 
 
72 
 
REFERENCES 
 
Abdullah, D.A., and Sabry, A.H., 2009.Bacterial quality of raw milk investigated by 
Escherichia coli and isolates analysis for specific virulence gene markers. Food Control, 20, 
913-917. 
 
Al-Kanhal, H. A., Abo-Tarboosh, H. M., Hamad, A. M., and Al-Shrawy, M. I., 1996. The 
quality of raw milk produced in Saudi Arabia. Journal of King Saud University, Agricultural 
Sciences, 8, 211–226. 
 
Aly, S. A. and Galal, E. A. 2002. Effect of milk pretreatment on the keeping quality of 
Domiati cheese. Pakistan Journal of Nutrition, 1, 132–136. 
 
Asmahan, A.A., and Warda, S.A.2011. Incidence of Esherichia coli in raw cow’s milk in 
Khartoum State. British Journal of Dairy Science, 2, 23-26. 
 
Banwart, G.J., 1989. Microorganisms Associated with Food. 2nd Edn., Basic Food 
Microbiology. Van Nostrand Reinhold, New York. 
 
Cagney, C., H., Crowley, G., Duffy, Sheridan, J.J., O’Brien, S., Carney, E., Anderson, W.M., 
Dowell, D. A., Blair, I. S. and Bisho, R. H.,  2004. Prevalence and numbers of Escherichia 
coli O157:H7 in minced beef and beef burgers from butcher shops and supermarkets in the 
Republic of Ireland. Journal of Food Microbiology, 21, 203-212. 
 
73 
 
Christen, G.L., Davidson P.M., McAllister J.S., and Roth, L.A. 1992. Coliform and other 
indicator bacteria. In: Mashall R.T. (ed.) Standard methods for the examination of dairy 
products. American public health association, Washington D.C.:247-269. 
 
Chirsten, G.L., Davidson, P.M., McAllister, J.S. and Roth, L.A., 1993. Coliform and other 
indicator bacteria. In: Marshall, R. T. ed. Standard methods for the examination of dairy 
products, 16th Ed. Chapter 7,Washington: American Public Health Association, p. 247-269. 
 
Chye, F. Y., Abdulla h, A., and Ayob, M. K. 2004. Bacteriological quality and safety of raw 
milk in Malaysia. Food Microbiology, 21,  535–541. 
 
Collins, C.H., Lyne,  P.M. and J. Grange., 1995. Microbiological Methods. In: Collins, C.H., 
P.M. Lyne and J. Grange (Eds.), Collins and Lyne’s. Butterworth- Heinemann, London. 
  
Dilielo, L.R., 1982. Methods in Food and Dairy Microbiology. AVI publishing Co. Inc. 
Westport Connt, USA, p. 39. 
 
Fox, B.A. and Cameron, A.G., 1995. In: Fox, B.A., Cameron, A.G. (Eds.), Food Science, 
Nutrition and Health. Edward Arnold, London. 
 
Gram, C., 1884. Uber die isolirte Farbung der Schizomyseten in SchnittAund 
Trockenpraparaton. Fortshnitte der Medicin, 2, 185-189. 
 
Gruetzmacher, T.J. and R.L. Bradley., 1999. Identification and control of processing 
variables that affect the quality and safety of fluid milk. Journal of Food Protection, 62, 625-
631. 
74 
 
 
Hayes, M.C., Ralyea, R.D., Murphy, S.C., Carey, N.R., Scarlett, J.M. and Boor, K.J., 2001. 
Identification and characterization of elevated microbial counts in bulk tank raw milk. 
Journal of Dairy Science, 84, 292-298. 
 
Houghtby, G.A., Maturin, L.J. and Koenig, E.K., 1993. Microbiological count methods. In: 
Marshall RT Ed. Standard methods for the examination of dairy products, 16th Ed. Chapter 6, 
Washington: American Public Health Association, p. 213-246. 
 
Hussein, H.S., and Sakuma, T. 2005. Prevalence of Shiga toxin-producing Escherichia coli in 
dairy cattle and their products. . Journal of Dairy Science, 88, 450–465. 
 
Jones, G.M., Bailey, T.L. and Roberson, J.R., 1998.Staphylococcus aureus mastitis: Cause, 
Detection, and Control. Virginia Cooperative Extension. Publication number 404-229.  
 
Lues, J.F.R., Venter, P. and Van der Westhuizen, H., 2003. Enumeration of potential 
microbiological hazards in milk from a marginal urban settlement in central South Africa. 
Food Microbiology, 20, 321-326. 
 
Lues, J.F.R., De Beer, H., Jacoby, A., Jansen, K.E. and Shale, K., 2010. Microbial qyality of 
milk produced by small scale farmers in a peri-urban area in South Africa. African Journal of 
Microbiology Research, 4, 1823-1830. 
 
75 
 
Lopes, L.M., Fabbricotti, S.H., Ferreira, A.J.P., Kato, M.A.M.F., Michalski, J. and Scaletsky, 
C.A., 2005. Heterogeneity among strains of diffusely adherent Escherichia coli isolated in 
Brazil. Journal of Clinical Microbiology, 43, 1968-1972. 
 
Maugeri, T.L., Carbone, M., Fera, M.T., Irrera, G.P., Gugliandolo. C., 2004. Distribution of 
potentially pathogenic bacteria as free-living and plankton-associated in a marine coastal 
zone. Journal of Applied Microbiology, 97, 354-361. 
 
Meng, J., Doyle, M.P., Zhao, T. and Zhao, S., 2007. Enterohemorrhagic Escherichia coli. In: 
Doyle, M.P., Beuchat, L.R. (Eds.), Food Microbiology: Fundamentals and Frontiers, third ed. 
ASM Press, Washington, DC. 
 
Meraz, I.M., Jiang, Z.D., Ericsson, C.D., Bourgeois, A.L., Steffen, R., Taylor, D.N., 
Hernandez, N. and DuPont, H.L., 2008. Enterotoxigenic Escherichia coli and diffusely 
adherent E. coli as likely causes of a proportion of pathogen-negative traveler’s diarrhea- A 
PCR based study. Journal of Travel Medicine, 15, 412-418.  
 
Maurelli, A.T., Fernández, R.E., Bloch, C.A., Rode, C.K. and Fasano, A., 1998. ―Black hole‖ 
and bacterial pathogenicity: A large genomic deletion that enhances the virulence of Shigella 
spp. and enteroinvasive Escherichia coli. Proceeds of the National Academy of Sciences, 95, 
3943-3948. 
 
Philips, J.D. and Griffiths, M.W., 1990. Pasteurized Dairy Products: The Constraints Imposed 
by Environmental Contamination. In: Nriagu, J.O. and M.S. Simmons (Eds.), Food 
Contamination from Environmental Sources. Wiley and Sons, New York, p. 387-456. 
76 
 
  
Rohde, J.E., 1985. Diarrheal Infections. In: Robinson, D. (Ed.), Epidemiology and the 
Community: Control of Disease in Warm Climate Countries. Churchill Livingstone, 
Edinburgh, p. 262-285. 
 
Sarkar, S., 2008. ―Diffusely adherent Escherichia coli (DAEC) as a cause of acute diarrhea‖. 
Texas Medical Center dissertations (via ProQuest). Paper AAI 1459796.  
 
Salji, J. P., Sawaya, W. N., and Ayaz, M. 1984. Fluid milk industry in the central province of 
Saudi Arabia. Journal of Dairy Science, 67, 1054–1060. 
 
Scaletsky, I.C.A., Fabbricotti, S.H., Aranda, K.R., Morais, M.B. and Fagundes-Neto, U., 
2002. Comparison of DNA hybridization and PCR assays for detection of putative 
pathogenic enteroadherent Escherichia coli. Journal of Clinical Microbiology, 40, 1254-
1258.  
 
Stewart, T.H., 1978. An Introduction to Public Health. Butterworth's, Durban. 
 
Soomro, A. H., Arain, M. A., Khaskheli, M. and Bhutto, B., 2002. Isolation of Escherichia 
coli from milk and milk products in relation to public health sold under market conditions at 
Tandojam. Pakistan Journal of Nutrition, 1,  151–152. 
 
Todar, K. 2008. Pathogenic Escherichia coli. http://textbookofbacteriology.net/e.coli. 2002. 
 
77 
 
Torres, J., López-Saucedo, C., Cerna, J.F., Villegas-Sepulveda, N., Thompson, R. and 
Velazquez, F.R., 2003. Single multiplex polymerase chain reaction to detect diverse loci 
associated with diarrhoeagenic Escherichia coli. Emerging Infectious Diseases, 9,  127-131. 
 
Tsai, L. Y., Palmer, C. L. and Sangeermano, L. R., 1993. Detection of Escherichia coli in 
sludge by polymerase chain reaction. Applied and Environmental Microbiology, 59, 353–357. 
 
Vieira, N., Bates, S.J., Solberg, O.D., Ponce, K., Howsmon, R., Cevallos, W., Trueba, G., 
Riley, L. and Eisenberg, J.N.S., 2007. High prevalence of enteroinvasive Escherichia coli 
isolated in a remote region of northern coastal Ecuador. American Journal of Tropical 
Medicine and Hygiene, 76, 528-533. 
 
Wang, G., Clifford, G. C. and Frank, G. R., 2002. Detection in Escherichia coli of the Genes 
Encoding the Major Virulence Factors, the Genes Defining the O157:H7 Serotype, and 
Components of the Type 2 Shiga Toxin Family by Multiplex PCR. Journal of Clinical 
Microbiology, 40, 3613–3619. 
 
 
78 
 
 
CHAPTER FOUR  
Occurrence of virulence genes associated with diarrheagenic Escherichia coli isolates 
from raw milk: Public Health Implications 
ABSTRACT 
 
Escherichia coli remains a major threat in many places around the globe as the causative 
agent of diarrhea, and its reservoir in raw milk may play an important role in the survival and 
transport of pathogenic strains. Diarrhoegenic E. coli (DEC) strains are a diverse group of 
food-borne pathogens and diarrhea causing pathogens with various levels of virulence for 
humans. The main objective of this present study was to determine the prevalence of 
pathogenic E. coli in raw milk. The raw milk samples of two dairy farms were screened for 
the presence of pathogenic E. coli strains using conventional PCR, targeting genes such as 
fliCH7, eagg, ial, eagg, lt, papC, ibeA and daaE. In samples from Middledrift dairy the 
virulent genes fliCH7 538 (44%), eae 19 (22%), lt 20 (23%), eagg 5 (7%), ial 4 (5%), papC 3 
(4%) and daaE 2 (2%) were present in higher amounts compared to those obtained from Fort 
Hare farm with fliCH7 16 (18%), eae 9 (10%), lt 7 (8%), eagg 7 (8%), ial 2 (2%), and the 
least was papC 1 (1%), while daaE 0 (0%) did not amplify.  All the targeted genes except for 
ibeA that encode pathogenicity for E. coli were successfully amplified by PCR confirming 
that the isolates were pathogenic strains. This demonstrates that there is a widespread 
distribution of potentially virulent E. coli strains in the environment and in food that may be a 
cause of concern for human health. 
  
Keywords: Escherichia coli, free-living, virulence markers, raw milk. 
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4.1 INTRODUCTION 
 
Despite the fact that Escherichia coli as a commensal bacteria can be found as intestinal 
microflora of a variety of animals including man, not all the strains are harmless, and some 
can cause debilitating and sometimes fatal diseases in humans as well as mammals and birds 
(Belanger et al., 2011).  Pathogenic strains are divided into intestinal pathogens causing 
diarrhea (diarrhoeagenic E. coli) and extraintestinal E. coli (ExPEC). Three main types of 
clinical syndrome can result from infection with one of these pathotypes: enteric and 
diarrheal diseases, urinary tract infections, and sepsis/meningitis (Croxen and Finlay, 2010). 
The E. coli pathotypes responsible for intestinal infections include enteropathogenic E. coli 
(EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAggEC), enteroinvasive E. coli (EIEC), diffusely adherent E. 
coli, necrotoxic E. coli, and cell-detaching E. coli (Kaper et al., 2004). Two additional E. coli 
pathotypes, collectively called extraintestinal pathogenic E. coli (Russo and Johnson, 2000) 
are responsible for extraintestinal infections. Extraintestinal pathogenic E. coli is composed 
of uropathogenic E. coli (UPEC) isolates that cause urinary tract infections, neonatal 
meningitis-associated E. coli (MNEC), and E. coli strains that cause septicaemia (Bekal et al., 
2003). Each pathotype has distinguishing characteristics related to its epidemiology, 
pathogenesis, clinical manifestations, and treatment. EPEC, DAEC, EIEC and ETEC are the 
most important of these groups in terms of total diarrheal episodes on a global scale, but in 
recent years verocytotoxin-producing E. coli (VTEC) has gained increasing interest due to 
the occurrence of numerous cases of clinical syndromes associated with the consumption of 
meat and meat products, and raw milk and dairy products 
(http://www.who.int/mediacentre/factsheets accessed Apr. 25, 2008; Anonymous, 2007). 
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Among the VTEC particular attention is paid to the enterohaemorrhagic E. coli (EHEC) 
subgroup, whose serotype O157:H7 has been recognized as cause of haemorrhagic colitis 
(HC) and haemolytic uraemic syndrome (HUS) in humans (Botteldoorn et al., 2003). The 
virulence factors of VTEC are related to Vt1 and Vt2 genes (Kaper et al., 1998). Other 
virulence factors have been identified in EHEC: a membrane protein intimin, encoded by the 
eae gene, and an enterohaemolysin, encoded by the HlyA gene (Stephan et al., 2008). VTEC 
strains are commonly isolated from healthy cattle, and the presence of haemolysis may be 
used as a marker to differentiate virulent VTEC from other less virulent strains (Gyles et al., 
1998). The study of the techniques to discriminate the various E. coli strains has received 
great attention during the last few years. In this field, biomolecular techniques are largely 
applied as they proved to be the most sensitive and specific (Rappelli et al., 2001; Gilgen et 
al., 1998; Fagan et al., 1999; Chapman et al., 2001; Belanger et al., 2003). In this chapter, we 
describe a conventional PCR assay for the simultaneous identification of strains of E. coli 
belonging to the eight principal virulence groups (VTEC (EHEC), EPEC, ETEC, EIEC, 
EAEC, DAEC, UPEC and NMEC) in raw milk.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1 DNA extraction 
 
DNA was extracted from E. coli isolates identified in chapter 3 and from a positive control 
strains for E. coli (ATCC 8739) (SABS No ESC 20) purchased from the South African 
Bureau of Standards (SABS), Pretoria, South Africa. The extraction was done as described in 
section 3.2.4 of chapter 3.  
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4.2.2 Pathotyping of E. coli 
 
Oligonucleotide primers targeting the fliCH7 gene encoding for Enterohemorrhagic E. coli 
structural flagella antigen H7,  eagg gene encoding for antiaggregation protein (dispersin) of 
Enteroaggregative E. coli ,ial gene encoding for invasion-associated locus of Enteroinvasive 
E.coli, eae gene encoding for Enteropathogenic E. coli intimin, Stx1and stx2 gene encoding 
for shigatoxin producing Enterohemorrhagic E. coli, lt gene encoding for heat-labile 
Enterotoxigenic E.coli, papC gene characterized by uropathogenic E. coli and ibe10  gene 
characterized by neonatal meningitis E. coli were used in the polymerase chain reaction 
following the conditions in Table 4.1. The reaction mixture for running PCR contained 12.5 
μl of 2X PCR master mix (0.05 units/μl Taq DNA polymerase in reaction buffer, 4 mM 
MgCl2, 0.4 mM dATP, 0.4 mM dCTP, 0.4 mM dGTP and 0.4 mM dTTP) (Thermo Scientific 
, SA), Nuclease free water (6.5 μl) (Thermo Scientific, SA), the cell lysates (5 μl) and 0.5 μl 
of the forward and reverse primer. PCR assay was carried out in a 25 μl reaction volume. 
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 Table 4.1-Primer sequences and expected size of PCR amplified gene targets of the pathogenic strains of Escherichia coli. 
 
Target 
strain  
Target 
gene 
Primer sequence (5’-3’) Conditions Amplicon 
size (bp) 
References 
NMEC IbeA TGGAACCCCCTCGTAATATAC 
CTGCCTGTTCAAGCATTGCA 
An initial denaturation step at 94
0
C for 5min, followed by 36 
cycles of 94
0
C for 35 seconds, annealing at 62
0
C for 30 seconds 
and elongation at 72
0
C for 1min. A final elongation step at 72
0
C 
for 5min. 
342 Celuba et al., 
2005 
EHEC flicH7 TACCATCGCAAAAGCAAC TCC            
GTCGGCAACGTTAGTGATACC 
Initial denaturation at 95
0
C for 15 minutes followed by 35 cycles 
of heat denaturation at 94
0
C for 45 seconds, primer annealing at 
55
0
C for 45 seconds and DNA extension at 68
0
C for 2 minutes. 
After the last cycle the samples were kept at 72
0
C for 5 minutes to 
complete synthesis of all strands. 
230 Wang et al., 
2000 
EIEC ial CTGGATGGTATGGTGAGG 
GGAGGCCAATTATTTCC                    
1 cycle for 2 minutes at 50
0
C, 1 cycle for 5 minutes at 95
0
C, 40 
cycles for 45 seconds at 95
0
C, 45 seconds at 55
0
C and 45 seconds 
at 72
0
C and a final extension step for 10 minutes at 72
0
C to 
complete synthesis of all strands. 
700 Presterl et 
al., 2003 
EAEC eagg AGACTCTGGCGAAAGACTGTATC 
ATGGCTGTCTGTAATAGATGAGAAC 
Initial denaturation at 95
0
C for 15 minutes followed by 35 cycles 
of heat denaturation at 94
0
C for 45 seconds, primer annealing at 
55
0
C for 45 seconds and DNA extension at 68
0
C for 2 minutes. A 
final elongation step at 720C for 5min. 
194 Kong et al., 
2002 
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EPEC eae TCAATGCAGTTCCGTTATCAGT 
GTAAAGTCCGTTACCCCAACC TG 
An initial denaturation step at 94
0
C for 15 min, followed by 35 
cycles of 94
0
C for 45 seconds, annealing at 55
0
C for 45 seconds 
and elongation at 68
0
C for 2 min. A final elongation step at 72
0
C 
for 5min. 
482 Stacy-Phipps 
et al., 1995 
ETEC lt GCACACGGA GCTCCTCAGTC 
TCCTTCATCCTTTCAATGGCTT 
An initial denaturation step at 95
0
C for 15 min, followed by 35 
cycles of 94
0
C for 45 seconds, annealing at 55
0
C for 45 seconds 
and elongation at 68
0
C for 2 min. A final elongation step at 72
0
C 
for 5min. 
218 Stacy-Phipps 
et al., 1995 
DAEC daaE GAACGTTGGTTAATGTGGGGTAA 
TATTCACCGGTCGGTTATCAGT 
An initial denaturation step at 94
0
C for 2 min, followed by 40 
cycles of 92
0
C for 30 seconds, annealing at 59
0
C for 30 seconds 
and elongation at 72
0
C for 30 secomds. A final elongation step at 
72
0
C for 5min 
300 Vidal et al., 
2005 
UPEC papC GACGGCTGTACTGCAGGGTGTGGC G 
ATATCCTTTCTGCAGGGATGCAATA 
An initial denaturation step at 94
0
C for 2 min, followed by 30 
cycles of 94
0
C for 1 min, annealing at 55
0
C for 1 min and 
elongation at 72
0
C for 1min. A final elongation step at 72
0
C for 
5min 
328 Stacy-Phipps 
et al., 1995 
EHEC stx1 CAGTTAATGTGGTGGCGAAGG 
 
CACCAGACAATGTAACCGCTG 
 
An initial denaturation step at 94
0
C for 5min, followed by 36 
cycles of 94
0
C for 35 seconds, annealing at 62
0
C for 30 seconds 
and elongation at 72
0
C for 1min. A final elongation step at 72
0
C 
for 5min. 
348 Celuba et al., 
2005 
EHEC stx2 ATCCTATTCCCGGGAGTTTAC G 
GCGTCATCGTATACACAGGAGC 
 
An initial denaturation step at 94
0
C for 5min, followed by 36 
cycles of 94
0
C for 35 seconds, annealing at 62
0
C for 30 seconds 
and elongation at 72
0
C for 1min. A final elongation step at 72
0
C 
for 5min 
584 Celuba et al., 
2005 
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4.2.3 Gel electrophoresis  
 
The PCR products (10 μl aliquots) were resolved in 1.8 % agarose gel containing 5 μl 
Ethidium bromide in 1X TBE buffer (40 mM Tris–HCl, 20 mM Naacetate, 1 mM EDTA, pH 
8) (Cagney et al., 2004; Wang et al., 2002) before being visualized and photographed under 
the Alliance System. A 100-bp DNA ladder was included on each gel as a molecular size 
standard. The electrophoresis was carried out at 100 V for 1 hour. 
 
 
4.3 RESULTS 
 
 
4.3.1 Molecular Characterization of E. coli 
 
Several genes representing E. coli pathotypes (EHEC, ETEC, EPEC, EAEC, UPEC, DAEC 
and EIEC) were amplified except for ibeA (NMEC) using PCR. Representative gel 
electrophoresis profiles of amplified products of target genes for pathogenic E. coli strains are 
illustrated in Figures 4.1 to 4.8.  
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                                     L1   1    2    3    4      5     6    7    8     9    10   11   12 13 
 
 
 
 
 
Figure 4.1- Amplification product from the primer pair of the fliCH7 gene. 
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970 and 
Lane 13:1836. The expected molecular size of fliCH7 fragments was 230 bp. 
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Figure 4.2- Amplification product from the primer pair of the eae gene.                               
 
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970 and 
Lane 13:1836. The expected molecular size of eae fragments was 482 bp. 
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Figure 4.3 - Amplification product from the primer pair of the lt gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415,    
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970, 
Lane 13:1836 and Lane 14: 1415.The expected molecular size of lt fragments was 218 bp. 
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Figure 4.4 - Amplification product from the primer pair of the ibeA gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970 and 
Lane 13:1836. The expected molecular size of ibeA fragments was 342 bp. There was no 
isolate identified with the ibeA gene. 
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Figure 4.5 - Amplification product from the primer pair of the papC gene.  
 
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024 and Lane 12: 1415. 
The expected molecular size of papC fragments was 328 bp. 
                                         L1  1    2    3    4     5    6     7    8     9    10  11    12 13  
 
 
 
 
 
Figure 4.6 - Amplification product from the primer pair of the eagg gene.  
 
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970, 
Lane 13: 100 bp ladder.The expected molecular size of eagg fragments was 197 bp. 
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Figure 4.7 - Amplification product from the primer pair of the ial gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970, 
Lane 13:100 bp ladder. The expected molecular size of ial fragments was 700 bp. 
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Figure 4.8 - Amplification product from the primer pair of the daaE gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: positive 
control, Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, 
Lane 7: 9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970 and 
Lane 13:1836. The expected molecular size of daaE fragments was 300 bp. 
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The number of E. coli isolates that were positive by PCR for fliCH7, eae, lt, papC, ial, eagg 
and daaE genes are summarized in Table 4.2. Middledrift dairy had the highest amount of 
virulence genes (42%) compared to Fort Hare dairy (38%) except for eagg gene which 
encodes for EAEC. The target gene of E. coli O157 (fliCH7) was noticed in the isolates 
obtained from both dairy farms in high amounts in comparison to other virulence genes. 
 
Prevalence rate was calculated by dividing the number of occurrences of the health indicator 
during the specified time period by the size of the population in which the health indicator 
occurs. The result is expressed as a percentage. The formula for calculating prevalence in 
PedNSS (Pediatric Nutrition Suveillance System) and PNSS is shown below. 
Prevalence= 
persons with a given health indicator during a specified time period 
population during the same time period 
X 100 
 
Prevalence of E. coli = number of pathogenic E. coli isolated from raw milk X 100 
                                     population during the same period 
                                    = 87÷400×100 
                                   = 21.75% 
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Table 4.2- Occurrence of pathogenic E. coli isolates from two dairy farms as indicated 
by presence of the target gene marker. 
 
4.4 Discussion 
 
Raw unpasteurized milk can harbor a variety of microorganisms and can be an important 
source of food-borne pathogens. The presence of foodborne pathogens in raw milk is due to 
direct contact with contaminated sources in the dairy farm environment and to udder 
excretion of an infected animal (Oliver et al., 2005). There are several reasons to be 
concerned about the microbial quality of raw unpasteurized milk and dairy products: first, 
outbreaks of disease in humans have been traced back to the consumption of unpasteurized 
milk, and also to pasteurized milk; second, unpasteurized milk is consumed directly by dairy 
producers, farm employees, their families and neighbours, and raw milk advocates; third, 
unpasteurized milk is consumed directly by a large segment of population via consumption of 
several types of cheese produced from unpasteurized milk (Collins et al., 1995; Oliver et al., 
2005). Nowadays, public health concern associated with microbial food safety is on the 
Location                                          Amplified genes 
fliCH7 eae Lt ibeA papC ial eagg daaE 
Middledrift 
dairy 
38 (44%)  19 (22%) 20 (23%) 0 (0%) 3 (4%) 4 (5%) 5 (6%) 2 (2%) 
Fort Hare 
dairy 
16 (18%) 9 (10%) 7 (8%) 0 (0%) 1 (1%) 2 (2%) 7 (8%) 0 (0%) 
Total 54 (62%) 28 (32%) 27 (31%) 0 (0%) 4 (5%) 6 (7%) 12 (14%) 2 (2%) 
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increase since E. coli is not only regarded as an indicator of faecal contamination but more 
likely as an indicator of poor hygiene and insufficient sanitary practices during milking. 
Detection of pathogenic bacteria in raw milk samples is still important, especially in more 
rural areas as it is easily available and economical. 
 
 
The results of this study confirm the poor microbiological quality of raw milk obtained from 
two dairy farms in the Eastern Cape Province of South Africa.  The PCR assays successfully 
amplified the target gene fliCH7 from 38 (44%) samples from Middledrift and 16 (18%) from 
Fort Hare Dairy which is characteristic of the Enterohaemorrhagic Escherichia coli O157:H.  
Enterohemorrhagic Escherichia coli (EHEC) strains are a subset of Shiga toxin (Stx)-
producing E. coli (STEC) strains that are isolated from human patients and are responsible 
for severe clinical symptoms, including diarrhea, hemorrhagic colitis, and hemolytic-uremic 
syndrome (Bettelheim, 2001; Elliot et al., 2001). An outbreak of E. coli O157:H7, which 
affected 16 people and caused 5 HUS cases among children, was linked to a yogurt made on 
a farm from pasteurized milk. Post-pasteurization contamination of milk was likely due to 
either inadequate cleaning or contamination from farmyard material (Murinda et al., 2004). 
This gene has also been isolated in E. coli from water by Okoh and Osode (2010).  
 
Target gene ibeA which is also characteristic of the Neonatal Meningitis Escherichia coli was 
not present in all the isolates from both dairy farms. Neonatal Meningitis E. coli is usually 
present in new borne and since this gene was not present in the isolates it proves that this 
gene cannot be present since new borne don’t drink raw milk. NMEC is a common inhabitant 
of the gastrointestinal tract and it is the most frequent cause of Gram-negative-associated 
meningitis in new borne. Fatality rates can approach 40% (Kaper et al., 2004), and survivors 
are usually burdened with severe neurological sequelae. 
94 
 
 
The lt gene which encodes for heat-labile Enterotoxigenic E. coli was amplified from 20 (22 
%) isolates in Middledrift and 7 (8%) from Fort Hare dairy farms. Enterotoxigenic 
Escherichia coli (ETEC) are an important cause of diarrhea in infants and in travelers from 
developed to underdeveloped countries, especially in regions of poor sanitation (Ericsson, 
2003). The ETEC are acquired by the ingestion of contaminated food and water, and adults 
living in endemic areas develop immunity. The disease condition manifests as a minor 
discomfort to a severe cholera-like syndrome and requires colonization by the microorganism 
and the elaboration of one or more enterotoxins (Evans et al., 1990; WHO, 2007). This gene 
has also been detected from water (Okoh and Osode, 2008). 
 
The ial gene which is found in Enteroinvasive Escherichia coli was also amplified from 4 
(5%) isolates in Middledrift dairy and 2 (2%) isolates from Fort Hare dairy.  EIEC has 
principally been associated with contaminated food and water (Gordillo et al., 1992; Maier, et 
al., 1973) although cases of person-to-person transmission of EIEC have been noted (Harris 
et al., 1985). After ingesting the organisms of EIEC, there is an invasion and adhesion of the 
epithelial cells of the intestine. The invasion of the cells can trigger a mild form of diarrhea or 
dysentery, often mistaken for dysentery caused by Shigella species. The illness is 
characterized by the appearance of blood and mucus in the stools of infected individuals or a 
condition called colitis (Todar, 2008). The illness is characterized by abdominal cramps, 
diarrhea, vomiting, fever, chills, and a generalized malaise. Outbreaks have been associated 
with hamburger meat and unpasteurized milk (Lan et al., 2004). This is the first report where 
EIEC has been isolated from raw milk in the Eastern Cape Province of South Africa. 
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Enteroaggregative Escherichia coli characterized by eagg gene was amplified from 5 (6%) 
isolates in Middledrift and 7 (8%) isolates from Fort Hare dairy. Enteroaggregative 
Escherichia coli is an emerging diarrheagenic pathogen associated with diarrheal illnesses 
among patients in developed and developing countries. This organism has been increasingly 
isolated and characterized around the world from human clinical, animal, and environmental 
samples (Yamamoto and Nakazawa, 1997; Kahali et al., 2004; Falcao et al., 2004). However, 
frequencies of Enteroaggregative Escherichia coli among patients with diarrhea in the 
Eastern Cape Province, South Africa, are not known.  
 
Enteropathogenic E. coli characterized by the presence of the eae gene was amplified from 
19 (22%) isolates in Middledrift and 9 (10%) isolates in Fort Hare dairy farm. EPEC strains 
are the oldest recognized category of diarrheogenic E. coli (Zuber, 1999) and are well known 
prominent cause of diarrhea, particularly in children in less developed countries (Tennant et 
al., 2009; Trabulsi et al., 2002). 
 
Uropathogenic E. coli which is characterized by papC gene was amplified from 3 (4%) 
isolates rom Middledrift and from 1 (1%) isolate in Fort Hare farm. If UPEC is ingested it 
can be capable of causing cystitis in the bladder and acute pyelonephritis in the kidneys 
(Alteri et al., 2009; Croxen and Finlay, 2010). 
 
The daaE gene which encodes diffusely adherent E. coli was only amplified from 2 (2%) 
isolates in Middledrift dairy. It is presumed that the virulence factor of the organism (DAEC) 
is diffuse attachment to the intestinal lining of the infected host (Sarkar, 2008). In a study 
carried out by Meraz et al., 2008, the major clinical symptoms of the patients carrying DAEC 
strains were found to include watery diarrhea in some instances with mucus and blood, 
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vomiting, with vomiting being more prominent as compared to diarrhea among children. The 
pathotypes identified in this study are all from feaces and could mean that the staff does not 
wash their hands after visiting the mens or ladies rooms 
 
The Act in South Africa which governs the safety of milk per se, and which sets standards to 
which milk and dairy products must confirm to is the foodstuffs, cosmetics and disinfection 
Act, No. 54 0f 1972.  According to this Act milk may not contain pathogenic organisms, 
extraneous matter or any inflammatory product or any substance which may render it unfit 
for consumption. Bacteriologically it may not contain more than 20 coliforms or any E. coli 
per ml. This study indicates that raw milk samples from both Middledrift and Fort Hare dairy 
were not satisfactory in course of public health standard as some pathogenic E. coli strains 
were detected from the milk samples.  
 
4.5 Conclusion and recommendations 
 
The results obtained in this study concluded that raw cow's milk available to consumers in the 
Eastern Cape, South Africa was contaminated with the opportunistic pathogen E. coli. High 
and strict preventive measures like regular washing and sterilization of dairy equipment, 
utensils, milker's hands, and animal udders, and eradication of diseased animals from the herd 
are highly recommended with the milker’s hands taking priority.  Teaching and training 
programs, for those working at the dairies, can possibly improve the situation 
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CHAPTER FIVE  
 
 
Frequency of antibiotic resistance determinants obtained from raw milk in two farms of 
the Eastern Cape Province 
ABSTRACT  
 
Monitoring of antimicrobial resistance (AMR) in bacteria has clinical and public health 
significance. This study was carried out to evaluate the antibiogram of the E. coli strains and 
to determine the genes that mediate antibiotic resistance. A total of 87 E. coli isolates, 50 
(57%) from Middledrift and 37 (43%) from Fort Hare dairy were subjected to antibiotic 
susceptibility testing. The genes implicated in antibiotic resistance (ermA, bla-Z, strA and 
tetA) were amplified using conventional PCR method. All of the isolates were 100% resistant 
to penicillin G and erythromycin and contained the erythromycin ermA gene and the 
penicillin G bla-Z gene. Middlefrift dairy farm showed intermediate resistance to 
streptomycin 30 (81.1%) and 32 (86.5%) for tetracycline while Fort Hare farm showed 48 
(96%) and 40 (40%) for streptomycin and tetracycline respectively.  However, strA gene 
which encodes for streptomycin and the tetA gene which encodes for tetracycline could not 
be amplified. The present results showed that the phenotypic antibiotic susceptibility patterns 
were similar to those obtained by genotyping done by conventional PCR for erythromycin 
and penicillin G but not in the case of streptomycin and tetracycline. Rapid and reliable 
methods for antibiotic susceptibility are important to determine the appropriate therapy 
decisions. 
Keywords: Antibiotic resistance, Escherichia coli, Erythromycin, Tetracycline, Penicillin G 
and Streptomycin. 
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5.1 Introduction 
 
The progressive emergence and rapid dissemination of antibiotic resistance in E. coli and its 
association with the use and consumption of antibiotics constitute a major health concern and 
have been considered a global crisis (Barkema et al., 2006; Velusamy et al., 2007). E. coli is 
the causative agent of most diarrheal diseases and is associated with serious diseases such as 
hemolytic uremic syndrome (HUS), meningitis and bloody diarrhea. (Kaper et al., 2004). 
Serious complications occur because of multiple-antibiotic resistant E. coli. As E. coli is 
representative of many drug resistant bacteria (Barbosa and Levy, 2000), it is necessary to 
study the ways to control this bacterium. Penicillin G the first antibiotic used in the control of 
E. coli developed resistance within approximately 2 years of its introduction and has 
increased gradually over the past 50 years (Barbosa and Levy, 2000). Other antibiotics 
thereafter also developed resistance to E. coli such as erythromycin, tetracycline, 
streptomycin, etc. Antibiotics used in animal husbandry, have led to the increasing concerns 
with regard to their contribution to the abundance and persistence of antibiotic resistance in 
populations of pathogenic, commensal, and nonpathogenic microorganisms (Auerbach et al., 
2007, Yang and Carlson, 2003). The overuse of antibiotics, chemicals such as disinfectants, 
antiseptics, pesticides together in control of mastitis and on farm maintenance, has resulted in 
a significant increase of antibiotic resistant bacteria in dairy farms (Schwartz et al., 2003). 
Bacteria may be defined as resistant when they are not susceptible to a concentration of 
antimicrobial agent such as antibiotics and this is indicative of the selection pressure exerted 
on bacteria (Cloete, 2003). The occurrence of antibiotics in hospital, residential, and dairy 
effluent, municipal wastewater have been reported in other parts of the world (Brown et al., 
2006; Miao et al., 2004; McArdell et al., 2003; Alder et al., 2001). Reinthaler and co-workers 
(2003) reported antibiotic resistance of E. coli in sewage and sludge. There are no reports (to 
my knowledge) available on antibiotics susceptibility patterns in pathogenic Escherichia coli 
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isolated from raw milk in the Eastern Cape Province of South Africa. This study therefore 
hypothesize that the raw milk from two dairy farms in this Province are potential reservoirs 
of multi resistant antibiotics. 
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Antimicrobial Susceptibility Determination 
 
The identified E. coli isolates from Chapter 3 were subjected to antibiotic sensitivity testing 
by the disc diffusion method (Bauer et al., 1966). The inocula of the E. coli isolates were 
prepared using the colony suspension method (EUCAST, 2003). Briefly, colonies were 
picked from 18-24 hour old cultures grown on Nutrient Agar (NA) were used to make 
suspension of the test organisms in saline solution to give an optical density of approximately 
0.1 at 600nm. The suspension was then diluted 1:100 by transfer of 0.1 ml of the bacterial 
suspension to 9.9 ml of sterile Nutrient Broth (NB) before use. Isolates were sub-cultured 
onto Mueller-Hinton agar (MHA) (BD Bioscience, Sparks, MD) and screened for 
susceptibility to locally produced commercial antimicrobial discs (Davies Diagnostics Pty 
Ltd) by the disk diffusion method (NCCLS 2000) using 10 antibiotics (Table 5.1). E. coli 
strain 8739 (American Type Culture Collection) was used as a reference control strain. Plates 
were incubated at 35 
o
C for 18-24 hours and zones of inhibition were interpreted as resistant 
or sensitive using the interpretative chart of the zone sizes of the Kirby – Bauer sensitivity 
test method (Cheesbrough, 2000). 
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Table 5.1-Antibiotics used for antibiotic susceptibility test 
 
Antibiotic Concentration 
  
Florfenicol 20 µg 
Neomycin 30 µg 
Erythromycin 15 µg 
Streptomycin 10 µg 
Penicillin G 10 µg 
Thrimethropim 5 µg 
Gentamicin 10 µg 
Tetracycline 30 µg 
Kanamycin 30 µg 
Chloramphenicol 30 µg 
 
 
5.2.2 Detection of resistant genes by molecular characterization 
 
Firstly DNA was extracted from E. coli isolates identified in chapter 3 and 4 and from a 
positive control strains for E. coli (ATCC 8739) (SABS No ESC 20) purchased from the 
South African Bureau of Standards (SABS), Pretoria, South Africa. The extraction was done 
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as described in section 3.2.4 of chapter 3. The presence of relevant antimicrobial resistance 
genes encoding for the streptomycin phosphotransferases (strA); the ermA gene which 
encodes for erythromycin, the tetA gene which encodes for tetracycline and the bla-Z gene 
which encodes for beta-lactamase enzyme (penicillin G) were determined by PCR (Velusamy 
et al., 2007). The ingredients for running PCR contained 12.5 μl of (2X) PCR Master Mix 
(0.05 units/μl Taq DNA polymerase in reaction buffer, 4mM MgCl2, 0.4mM dATP, 0.4 mM 
dCTP, 0.4mM dGTP and 0.4mM dTTP (Thermo Scientific, SA), 6.5 μl of nuclease free water 
(Thermo Scientific, SA), 0.5 μl of each primer and 5 μl of DNA  . The PCR assays will be 
carried out in a 25 μl reaction volume (Table 5.2). 
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Table 5.2-Oligonucleotide sequences and predicted sizes for PCR amplification of different antimicrobial resistance genes from E. coli. 
 
Target 
gene 
Nucleotide sequence (5’-3’) Conditions Amplicon size 
(bp) 
References 
strA CTTGGTGATAACGGCAATTC  
CCAATCGCAGATAGAAGGC 
Pre-incubation at 94°C for 4 minutes. Thirty PCR cycles will run under 
the following conditions: denaturation at 94°C for 45s, primer annealing 
at optimum temperature for 45s and DNA extension at 72°C for 45s in 
each cycle. After the last cycle PCR tubes will be incubated for 7 
minutes at 72°C and held at 4°C (Velusamy et al., 2007). 
  548 Gebreyes and 
Altier, 2002 
 
ermA AAGCGGTAAACCCCTCTGA 
 
TTCGCAAATCCCTTCTCAAC 
 
Reactions were hot started for 5 min at 94°C. The reaction mixtures were 
then subjected to 35 PCR cycles (94°C for 2 min, 2 min at 55°C, and 1 
min at 72°C). A final elongation step at 72°C for 7 min was also applied. 
190 Duran et al., 
2012 
bla-Z ACTTCAACACCTGCTGCTTC 
TGACCACTTTTATCAGCAACC 
Reactions were hot started for 5 min at 94°C. The eaction mixtures were 
then subjected to 35 PCR cycles (94°C for 2 min, 2 min at 55°C, and 1 
min at 72°C). A final elongation step at 72°C for 7 min was also applied. 
173 Duran et al., 
2012 
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tetA GGCCTCAATTTCCTGACG  
 
AAGCAGGATGTAGCCTGTGC 
Pre-incubation at 94°C for 4 minutes. Thirty PCR cycles will run under 
the following conditions: denaturation at 94°C for 45s, primer annealing 
at optimum temperature for 45s and DNA extension at 72°C for 45s in 
each cycle. After the last cycle PCR tubes will be incubated for 7 
minutes at 72°C and held at 4°C (Velusamy et al., 2007). 
372 Guillame et al. 
(2000) 
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5.2.3 Gel electrophoresis  
 
The PCR products (10 μl aliquots) were resolved in 1.8 % agarose gel containing 5 μl 
Ethidium bromide in 1X TBE buffer (40 mM Tris–HCl, 20 mM NaAcetate, 1 mM EDTA, pH 
8) (Cagney et al., 2004; Wang et al., 2002) before being visualized and photographed under 
the Alliance System. A 100-bp DNA ladder was included on each gel as a molecular size 
standard. The electrophoresis was carried out at 100 V for 1 hour. 
 
5.3 RESULTS 
 
5.3.1 Antibiotic susceptibility test 
  
E. coli from both farms showed 100% resistance to both erythromycin and Penicillin G and 
intermediate resistance to streptomycin and tetracycline (Table 5.3 and 5.4). 
 
Figure 5.1- Kirby Bauer susceptibility assay results 
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Table 5.3-Antibiotic susceptibility testing of E. coli isolates from Fort Hare farm 
 
 
 
Antibiotics 
E. coli (n=37) 
S I R 
Streptomycin (10 µg) 7 (18.92%) 30 (81.08%) 0 (0%) 
Neomycin (30 µg) 37 (100%) 0 (0%) 0 (0%) 
Gentamicin (10 µg ) 37 (100%) 0 (0%) 0 (0%) 
Penicillin G (10 µg) 0 (0%) 0 (0%) 37 (100%) 
Thrimethropim (5 µg) 37 (100%) 0 (0%) 0 (0%) 
Tetracycline (30 µg) 5 (13.50%) 32 (86.50%) 0 (0%) 
Florfenicol (20 µg) 37 (100%) 0(0%) 0 (0%) 
Kanamycin (30 µg) 37 (100%) 0 (0%) 0 (0%) 
Erythromycin (15 µg) 0 (0%) 0 (0%) 37 (100%) 
Chloramphenicol (30µg) 37 (100%) 0 (0%) 0 (0%) 
    
S= susceptible, I= intermediate, R= resistant 
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Table 5.4- Antibiotic susceptibility testing of E. coli isolates from Middledrift farm 
  
 
Antibiotics 
E. coli (n=50 ) 
S I R 
Streptomycin (10 µg) 2 (4%) 48 (96%) 0 (0%) 
Neomycin (30 µg) 50 (100%) 0 (0%) 0 (0%) 
Gentamicin (10 µg ) 50 (100%) 0 (0%) 0 (0%) 
Penicillin G (10 µg) 0 (0%) 0 (0%) 50 (100%) 
Thrimethropim (5 µg) 50 (100%) 0 (0%) 0 (0%) 
Tetracycline (30 µg) 10 (20%) 40 (80%) 0 (0%) 
Florfenicol (20 µg) 50 (100%) 0(0%) 0 (0%) 
Kanamycin (30 µg) 50 (100%) 0 (0%) 0 (0%) 
Erythromycin (15 µg) 0 (0%) 0 (0%) 50 (100%) 
Chloramphenicol(30 µg) 50 (100%) 0 (0%) 0 (0%) 
 
S= susceptible, I= intermediate, R= resistant 
 
5.3.2 Molecular characterization of resistance genes 
 
Amplification of resistance genes was attained on bla-Z and ermA genes but not on tetA and 
strA genes. Representative gel electrophoresis profiles of the target genes for antibiotic 
resistance are illustrated in Figures 5.1 and 5.2.  
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                          L1  1     2     3    4     5    6     7    8     9   10   11  12  13 
 
 
 
 
 
 
Figure 5.2- Amplification product from the primer pair of the ermA gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: H248, 
Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, Lane 7: 
9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 12:1970 and Lane 
13:1836. The expected molecular size of ermA fragments was 190 bp. 
 
                     L1   1    2     3    4     5    6     7    8     9    10   11  12  13  
 
 
 
 
 
 
Figure 5.3- Amplification product from the primer pair of the bla-Z gene.  
Lane L1: Low Range 100 bp DNA Ladder (Fermentas Life Sciences, SA); Lane 1: 9004, 
Lane 2: negative control, Lane 3: 1970, Lane 4: 8195, Lane 5: 1836, lane 6: 1415, Lane 7: 
9010, Lane 8: H248, Lane 9: 8111 Lane 10: 8073, Lane 11: 9024, Lane 11:1970 and Lane 
13:1836.The expected molecular size of bla-Z fragments was 173 bp. 
 
190 bp 
173 bp 
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All the isolates resistant to Penicillin G and erythromycin contained amplicons for bla-Z and 
ermA respectively. However there was no amplification for strA and tetA (Table 5.5). 
 
Table 5.5- Occurrence of resistant determinants of penicillin G and erythromycin 
isolated from raw milk in two dairy farms as indicated by presence of the target gene 
marker. 
 
Location                               Amplified genes 
ermA bla-Z strA tetA 
Middledrift dairy 50 (100%) 50 (100%) 0 (0%) 0 (0%) 
Fort hare dairy  37 (100%) 37 (100%) 0 (0%) 0 (0%) 
 
 
5.4 DISCUSSION 
 
Many bacteria develop resistance mechanisms enabling them to inactivate antimicrobial 
compounds in their environment. Genetic exchange between similar or different bacterial 
species may result in the spread of resistant genes (Prescott et al., 1996). Pathogens in 
animals that are used for food products pose one of the greatest risks for human health, as this 
is a major route for the transfer of bacteria from animals to humans (Mevius et al., 2005). The 
incorrect use of antibiotics in the treatment of diseases such as mastitis and for use in feed as 
growth promoters has led to the assumption that antibiotic resistance in bacteria could 
become widespread because of the transmission of resistant zoonotic and non-zoonotic 
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bacteria via food (Mevius et al., 2005). This could have serious impact on the treatment of 
bacterial pathogens causing disease in humans if similar antibiotics are used (Shyrock, 2004). 
Veterinarians are ethically required to administer antibiotics in such a manner as to protect 
animals and prevent spread of disease. In addition, the spread of zoonoses to humans must 
also be prevented and the human safety must be ensured (Passantino, 2007).  
 
Multiple resistances of the pathogenic E. coli isolates were found in the tested antimicrobial 
agents. The isolates showed a 100% resistance to Penicillin G and erythromycin. In this study 
all E. coli isolates were found to be resistant to penicillin G and erythromycin, our results are 
similar to what Osode (2008) have reported. The resistance of E. coli to β-lactams antibiotics 
(penicillin G) could be associated with the predominant use of penicillin for treatment of 
animal diseases; this result agrees with other results regarding the increase in incidence of β-
lactam antibiotics resistance (Alekshun and Levy, 2000; Jovetic, et al., 2010; Al-Thani and 
Al-Ali, 2012). Erythromycin is a macrolide containing large cyclic molecule. Erythromycin 
in E. coli is predominantly mediated by erythromycin resistant methylases encoded by the 
erm gene. ErmA has been reported as having the most prevalent resistance in Staphyloccocci 
and is usually associated with inducible resistance. ErmA and ErmC are the most prevalent 
genes in human infection (Nicola et al., 1998). The resistance of organisms to macrolides is 
mediated by chloramphenicol acetyl transferase enzyme in some organisms (Scalet et al., 
2010). All E. coli isolates showed high susceptibility to the antibiotics gentamicin and 
neomycin in our study a result also similar to Ibitsam and El Owni (2009) and Osode (2008). 
High susceptibility was revealed in the antibiotic kanamycin and thrimethropim a similar 
result to Obi et al., (2008). The strA gene which encodes for streptomycin and the tetA gene 
which encodes for tetracycline were not present in the isolates using conventional PCR. The 
results in our study showed that the phenotypic antibiotic susceptibility patterns were similar 
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to those obtained by genotyping done by conventional PCR for erythromycin and penicillin G 
but not in the case of streptomycin and tetracycline. Tetracycline and streptomycin are not 
only coded in the plasmid that carries the tetA and strA genes, other genes may also be 
involved. Streptomycin and tetracycline resistance genes strA and tetA respectively were also 
found positive by PCR method in 2 (4%) isolates and 10 (20%) isolates in Middledrift farm, 
whereas in Fort Hare dairy they were found to be positive in 7 (18.92%) isolates and 5 
(13.50%) isolates. The accurate and rapid diagnosis of antibiotic resistance genes in the 
treatment of Esherichia coli infections is extremely important in preventing the spread of 
infections. PCR-based molecular methods are often preferred for determination of antibiotic 
resistance genes (Woodfrord and Sundsfjord, 2005). An explanation for the extra bands in 
some of the lanes is that the primers are hybridized to secondary sites of template and as a 
result of miss priming (Titus, 1991). 
 
Antibiotics have been used for many years to eliminate bacterial pathogens causing disease. 
In the case of mastitis, it is important to note that antibiotic therapy cannot be relied upon to 
reduce the incidence of mastitis as a stand-alone anti-mastitis action. Isolation of bacterial 
agents and antimicrobial susceptibility test are important in reducing the occurrence of drug 
resistance and increase the production of milk and milk products. Failure to do so may cause 
the emergence of multidrug resistance in these organisms. 
 
5.5 Conclusion and recommendations 
 
The degree of antibiotic resistance exhibited by most of the isolates in this study is 
satisfactory. Given the growing number of reports of multidrug resistance to pathogenic E. 
coli isolates, it is evident that further research is still needed in this area. Given the severity of 
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the clinical manifestations of the diseases in humans and the inability and/or the potential 
risks of antibiotic administration for treatment, it appears that the most direct and effective 
measure towards ensuring public health is the prevention of E. coli infections in humans. 
Although finding effective pre-harvest control measures is not easy, approaches should focus 
on reducing the pathogens’ incidence in foods and water. 
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CHAPTER SIX  
GENERAL DISCUSSION 
 
Escherichia coli remains a major threat in many places around the globe as the causative 
agent of diarrhea, and its reservoir in raw milk may play an important role in the survival and 
transport of pathogenic strains. This study showed that target genes of fliCH7, eagg, ial, 
eagg, lt, papC and daaE that encode pathogenicity for E. coli were successfully amplified by 
PCR confirming that the isolates were pathogenic strains. Contamination of unpasteurized 
raw milk is a major human health issue. Certain types of Escherichia coli are among the 
pathogens commonly found in unpasteurized raw milk which can cause gastrointestinal 
illness. Since a lot of people still drink raw milk, especially in rural areas, this will emphasize 
the need for educational efforts on health risks associated with consumption of raw 
unpasteurized milk. 
 
Resistance is common where antibiotics are heavily used, and additionally antibiotic resistant 
bacteria are present in raw milk due to the use of antibiotics in the treatment of mastitis 
(Barkema et al., 2006). The antibiotic resistance patterns of the isolates in this study 
corroborate results from previous investigations (Obi et al., 2004). All isolates were resistant 
to penicillin G and erythromycin. High susceptibility patterns were seen in Florfenicol, 
chloramphenicol, neomycin, and gentamicin. All E. coli isolates showed high susceptibility 
to the antibiotics gentamicin and neomycin in our study a result also similar to Ibitsam and El 
Owni (2009) and Okoh and Osode (2010). A low level of resistance was seen amongst 
streptomycin and tetracycline by the disk diffusion method. The strA gene which encodes for 
streptomycin and the tetA gene which encodes for tetracycline were not present in the isolates 
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using conventional PCR. The results in our study showed that the phenotypic antibiotic 
susceptibility patterns were similar to those obtained by genotyping done by conventional 
PCR for erythromycin and penicillin G but not in the case of streptomycin and tetracycline. 
Tetracycline and streptomycin are not only coded in the plasmid that carries the tetA and strA 
genes, other genes may also be involved. Streptomycin and tetracycline resistance genes strA 
and tetA respectively were also found positive by PCR method in 2 (4%) isolates and 10 
(20%) isolates in Middledrift farm, whereas in Fort Hare dairy they were found to be positive 
in 7 (18.92%) isolates and 5 (13.50%) isolates. The accurate and rapid diagnosis of antibiotic 
resistance genes in the treatment of Esherichia coli infections is extremely important in 
preventing the spread of infections. PCR-based molecular methods are often preferred for 
determination of antibiotic resistance genes (Woodfrord and Sundsfjord, 2005). 
 
In summary this chapter presents a series of concluding remarks regarding the set objectives. 
The prevalence of pathogenic E. coli strains was ascertained. The antibiotic susceptibility 
profiles of the isolated E. coli strains were elucidated and the genes responsible for antibiotic 
resistance were determined.  
 
Conclusion and Recommendations 
 
The results obtained in this study concluded that raw cow's milk available to farmers and 
their families, dairy workers and neighbours in two dairy farms of the Eastern Cape Province 
of South Africa was contaminated with pathogenic E.coli. High and strict preventive 
measures like regular washing and sterilization of dairy equipment, utensils, milker's hands, 
and animal udders, and eradication of diseased animals from the herd are highly 
125 
 
recommended. Teaching and training programs, for those working at the dairies, can possibly 
improve the situation. Also, the degree of antibiotic resistance exhibited by most of the 
isolates in this study is satisfactory. Given the growing number of reports of multidrug 
resistant to pathogenic E.coli isolates, it is evident that further research is still needed in this 
area. Given the severity of the clinical manifestations of the diseases in humans and the 
inability and/or the potential risks of antibiotic administration for treatment, it appears that 
the most direct and effective measure towards ensuring public health is the prevention of 
E.coli infections in humans. Although finding effective pre-harvest control measures is not 
easy, approaches should focus on reducing the pathogens’ incidence in foods and water and 
on consumer education. Major and/or minor limitations of the study: Farm managers do not 
want to be disturbed when milking because sample collection disturbs the process; they are 
concerned about time and money since these are commercial dairy farms. 
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APPENDIX 
Table 1-API 20E results Middledrift dairy (n=72) 
 
Cow tag  Identity (%) 
1. 9005 Escherichia coli 96,6 
2. 2055 Esherichia coli 98.5 
3. 7021  Esherichia coli 65.5 
4. 9090 Esherichia coli 96,6 
5. 2881 Escherichia coli 76.5 
6. 7074  Esherichia coli 96,6 
7. 1420  Esherichia coli 99.9 
8. 7050  Esherichia coli 64.4 
9. 8131 Esherichia coli 93.3 
10. H248 Esherichia coli 94.5 
11. 8111 Esherichia coli 95,5 
12. 0002 Esherichia coli 100 
13. 100028 Esherichia coli 98.8 
14. 10064 Esherichia coli 98.4 
15. 7003      Esherichia coli 94.3 
16. 9069 Esherichia coli 76,8 
17. 2249 Esherichia coli 96,6 
18. 2334 Esherichia coli 98.5 
19. 9088  Esherichia coli 100 
20. 2327  Esherichia coli 99.8 
21. 0083 Esherichia coli 99.9 
22. 2470 Kluyvera ssp 76.5 
23. 2105 Esherichia coli 98.5 
129 
 
24. 2124 Enterobacter cloacae 65.5 
25. 8254 Esherichia coli 96,6 
26. 2043 Escherichia coli 76.5 
27. 0147 Esherichia coli 93.3 
28. 2361 Esherichia coli 94.5 
29. 9043 Esherichia coli 95,5 
30. 2592 Esherichia coli 100 
31. 2283 Esherichia coli 98.8 
32. 0026 Esherichia coli 98.4 
33. 2098 Enterobacter cloacae 94.3 
34. 2266 Esherichia coli 76,8 
35. 2331  Esherichia coli 96,6 
36. 2503 Esherichia coli 93.3 
37. 9056 Esherichia coli 94.5 
38. 2437 Esherichia coli 95,5 
39. 7048 Esherichia coli 100 
40. 2461 Esherichia coli 98.8 
41. 09103 Esherichia coli 98.4 
42. 8136 Escherichia coli 76.5 
43. 011 Esherichia coli 93.3 
44. 2073 Esherichia coli 100 
45. 2352 Esherichia coli 98.8 
46. 096 Esherichia coli 94.5 
47. 2261 Esherichia coli 95,5 
48. 9024 Esherichia coli 98.8 
49. 2503 Esherichia coli 76.8 
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50. 8073 Esherichia coli 99.0 
51. 2091 Esherichia coli 98.4 
52. 2613 Esherichia coli 97.9 
53. 2079 Esherichia coli 99.9 
54. 8244 Esherichia coli 76.9 
55. 2077 Esherichia coli 76.8 
56. 9112  Esherichia coli 94.3 
57. 0946 Enterobacter cloacae 99.9 
58. 8128 Esherichia coli 99.9 
59. 6596 Esherichia coli 96,8 
60. 8050  Esherichia coli 99.9 
61. 2592 Esherichia coli 98.9 
62. 8313 Esherichia coli 99.9 
63. 2011 Esherichia coli 76.4 
64. 0012 Esherichia coli 99.9 
65. 8405 Esherichia coli 99.8 
66. 2588 Esherichia coli 98.9 
67. 8361 Esherichia coli 76.4 
68. 0026 Esherichia coli 98.9 
69. 8171 Enterobacter cloacae 98.5 
70. 8131 Esherichia coli 76.4 
71. 2598 Esherichia coli 75.9 
72. 7001 Esherichia coli 78.9 
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Table 2-API 20E results Fort Hare dairy (n=68) 
Cow tag  Identity (%) 
1. 7022 Esherichia coli 100 
2. 7060 Esherichia coli 98.8 
3. 9021 Esherichia coli 98.4 
4. 7041 Enterobacter cloacae 94.3 
5. 8195 Esherichia coli 76,8 
6. 1960 Esherichia coli 96,6 
7. 8110  Esherichia coli 98.5 
8. 7053 Serratia liquefaziens 100 
9. 8031  Esherichia coli 99.8 
10. 9816  Esherichia coli 99.9 
11. 1760 Esherichia coli 76.5 
12. 1415 Esherichia coli 76.8 
13. 8195 Esherichia coli 99.0 
14. 1836 Esherichia coli 98.4 
15. 1970 Esherichia coli 97.9 
16. 1544 Esherichia coli 94.3 
17. 1194 Esherichia coli 99.9 
18. 1254 Esherichia coli 76.9 
19. 8122 Esherichia coli 76.8 
20. 8100  Esherichia coli 94.3 
21. 1041 Enterobacter cloacae 99.9 
22. 1170 Esherichia coli 99.9 
23. 7029 Esherichia coli 96,8 
24. 8088 Esherichia coli 100 
25. 1376 Esherichia coli 98.8 
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26. 1051 Esherichia coli 94.5 
27. 1797 Esherichia coli 95,5 
28. 1772 Esherichia coli 98.8 
29. 10276 Esherichia coli 76.8 
30. 7053 Esherichia coli 99.0 
31. 1859 Esherichia coli 98.4 
32. 1400 Esherichia coli 97.9 
33. 6375 Esherichia coli 99.9 
34. 1890 Esherichia coli 76.9 
35. 1757 Esherichia coli 76.8 
36. 6346  Esherichia coli 94.3 
37. 1121 Esherichia coli 99.9 
38. 1618 Esherichia coli 96,8 
39. 1881 Esherichia coli 99.9 
40. 1636 Esherichia coli 98.9 
41. 1942 Esherichia coli 99.9 
42. 10122 Esherichia coli 76.4 
43. 8045 Esherichia coli 99.9 
44. 1611 Esherichia coli 99.8 
45. 7023 Esherichia coli 98.9 
46. 1900 Esherichia coli 76.4 
47. 1960 Esherichia coli 98.9 
48. 1961 Esherichia coli 99.9 
49. 1749 Esherichia coli 96,8 
50. 10040 Esherichia coli 99.9 
51. 1008 Esherichia coli 98.9 
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52. 1194 Esherichia coli 99.9 
53. 1915 Esherichia coli 76.4 
54. 1396 Esherichia coli 99.9 
55. 1002 Esherichia coli 99.8 
56. 1317 Esherichia coli 98.9 
57. 1174 Esherichia coli 76.4 
58. 1544 Esherichia coli 98.9 
59. 8132 Esherichia coli 76,8 
60. 1671  Esherichia coli 96,6 
61. 1618 Esherichia coli 93.3 
62. 1586 Esherichia coli 94.5 
63. 9210 Esherichia coli 95,5 
64. 1037 Esherichia coli 100 
65. 1835 Esherichia coli 98.8 
66. 1316 Esherichia coli 98.4 
67. 7044 Escherichia coli 76.5 
68. 1829 Esherichia coli 93.3 
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Figure 1-Illustration of Gram negative rods isolated from raw milk observed under a light 
microscope. 
